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Diagnostic methods to effectively image dense breast tissue (DBT) can pose challenges 
for breast cancer screening. While conventional mammography is the gold standard for 
breast cancer screening, this technique has a low sensitivity to DBT and can miss about 
78% of cancers in DBT, but magnetic resonance imaging (MRI) has a high sensitivity for 
imaging DBT, and produces a smaller number of false positives. The purpose of this 
study was to determine the extent to which conventional mammograms can miss breast 
cancer in women with DBT and to determine if an adjunct method of imaging DBT 
might detect breast cancers that are missed by mammography alone. Quantitative data 
were collected from a sample of 300 randomly selected participants using surveys. SPSS 
statistical software was used to analyze the data with the factor analysis method. 
Qualitative data were collected by telephone interviews from 10 women who were 
patients of a breast cancer center. NVivo software was used to analyze the data with the 
thematic analysis method. All analyses were guided by theoretical framework of von 
Bertalanffy’s general systems theory, Miller’s living systems theory, and the theory of 
intelligent medical diagnosis. Key results determined that a significant number of women 
with DBT had breast cancer that was undetected by mammograms; results also showed 
that women with DBT can benefit from breast cancer screening by adding an adjunct 
screening method (e.g., MRI). This study may contribute to social change by making the 
breast cancer screening community aware of the potential benefit of adding MRI as an 
adjunct to conventional screening so that more breast cancers are detected in the early 
stages of the disease. 
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Chapter 1: Introduction to the Study   
Introduction 
In 2010, the last year for which the Centers for Disease Control and Prevention 
(CDC) has figures, the leading cause of death in women was heart disease (23.5%), 
followed closely by all cancers at 22.1% (cdc.gov). The National Cancer Institute (NCI) 
predicted that in 2013, over 876,000 women would be diagnosed with breast cancer in the 
United States (2010). Of that number, it was expected that nearly 40,000 would die from 
the disease. There are risk factors for heart disease, and lifestyle modifications may 
ameliorate the time of onset or severity of the disease, but estrogen and progesterone in 
women are the elements that fuel breast cancer, so gender itself is the major risk factor.  
Early detection of breast cancer is currently the single most effective way to 
modify the course of the disease, and treatment may then be made through surgery, 
radiology, chemotherapy—or a combination (ACS, 2013).  . Cancer registries, such as 
the American Cancer Society (ACS) and the American College of Radiology (ACR), 
recommend mammography as the diagnostic imaging tool for screening women for 
breast cancer (ACS, 2013). Conventional mammography will usually detect cancers, but 
it has a lower sensitivity to dense breast tissue (DBT) and can miss breast cancers in that 
kind of tissue.   
Breast density is measured by a tool called Breast Imaging Reporting and Data 
System (BI-RADS). When conventional mammographic techniques are used to image 





differentiation between the two difficult (Boyd et al., 2010). Breast cancer can be 
camouflaged in DBT because dense or glandular tissues have densities that are similar to 
surrounding tissues. If breast density is high, there is a greater amount of glandular 
tissues than fatty tissues; if breast density is low, there is a higher amount of fat than 
glandular tissues. In DBT, conventional mammograms cannot effectively detect cancer in 
those dense areas of breast tissue (ACR, 2013).  
In this study, I explored the effectiveness of ultrasonography and magnetic 
resonance imaging (MRI) as adjuncts to mammography screening DBT for breast cancer. 
The sensitivity of these imaging options were compared and contrasted to evaluate 
whether ultrasonography or MRI should be adjuncts in conventional mammography for 
breast cancer screening. This investigation was important because the outcome could 
build upon research that suggests that an additional method is needed to more accurately 
screen DBT and potentially save lives of women whose breast cancers might otherwise 
go undetected through conventional imaging (ACR, 2013).  
Chapter 1 is a presentation of information about the practice of mammography 
alone to screen for breast cancer and includes a discussion of the two additional imaging 
options, ultrasonography and MRI, to determine their efficacy. The chapter also includes 
the nature of the study, the purpose of the study, the conceptual framework, the 
hypotheses to support the research statement, the assumptions, scope and delimitations, 






It was not until prominent women such as Betty Ford and Nancy Reagan went 
public with their diagnoses and treatment for breast cancer in the 1980s that widespread 
attention was paid to the disease (Braun, 2003). Nancy Brinker, who established Susan G. 
Komen for the Cure in 1982 (named for Brinker’s sister who died from the disease at the 
age of 36) helped to bring the subject of breast cancer to the forefront (Harrison, 2013). 
The wider public became then aware of the disease, its impact, and its complications 
(Harrison, 2013). The openness about the issue of breast cancer in the 1980s resulted in 
increased emphasis on early detection through breast self-examinations and scheduling 
mammograms and having clinical breast examinations (Harrison, 2013). 
Although mammography remains the standard of screening for breast cancer, the 
efficacy and sensitivity of mammographic techniques for imaging DBT are concerns 
(Drukteinis et al., 2013). In the United States, 40% of all women who had breast 
screening with mammography had DBT (NCI, 2012). At the New York Cancer Center in 
2009, 500 women, aged 40-79 years, who had mammograms were found to have DBT in 
the following proportions: 74% in their 40s, 54% in their 50s, 42% in their 60s, and 31% 
in their 70s (Nelson et al., 2009).  
DBT can mask breast tissue that is cancerous and aggressive, causing these 
aggressive breast cancers to go undetected before they are treated (Yaghjayn et al., 2011). 
Adjunct imaging techniques, such as ultrasonography and MRI, are recommended by the 





high risk for breast cancer (ACR, 2012). The high-risk group of women with breast 
cancer is in the group with known BRCA (breast cancer) mutation carriers and first-
degree relatives who are carriers of the breast cancer gene (Berg, 2009). Other women 
who do not fit into this category, such as those with DBT, may not have the option of 
having an MRI tool as a screening mechanism (Berg, 2009). One of the many advantages 
of MRI for screening women with DBT is having a more accurate and faster diagnosis 
and treatment plan if there are cancerous lesions in the DBT (Berg, 2009).     
Ultrasonography also complements conventional mammography for dense breast 
screening, but this imaging modality has several setbacks: It is dependent on the skills of 
the operator and there is a shortage of operators (ACR, 2014). The technique can also fail 
to identify small lesions and provides more false positive findings than conventional 
mammograms (Youk & Kim, 2010). Although ultrasonography and MRI are used for 
breast imaging, MRI is typically used only for the high-risk population, not for routine 
breast screening of DBT.  
Problem Statement 
The use of conventional mammography for breast cancer screening can miss 
breast cancer in DBT (ACR, 2014; Susan G. Komen, 2013). With the probability of 
breast cancer occurrence at one in eight women, there is a need for an effective screening 
process for those with DBT (ACS, 2013; NCI, 2012), since early detection provides the 
potential for saving more lives. In 2013, Harvard Health Publications published the 





(2013). Conventional mammography, ultrasonography, and MRI imaging were all used, 
and the results showed that MRI was the most accurate at finding breast cancer; biopsies 
confirmed that MRI found 100% of breast cancer while conventional mammography and 
ultrasonography found  16% of breast cancer. 
Even though mammography alone for breast screening can miss tumors and 
cancers that are masked by glandular breast tissues—because X-rays have a low 
sensitivity to glandular tissues—organizations such as the NCI and ACR do not currently 
recommend MRI to screen for DBT (Berg, 2009). Ultrasonography can detect cancers 
and tumors in glandular tissues, but studies have shown that its use for imaging DBT has 
led to detection of small benign tumors and a greater number of false positives—and thus 
an increased breast biopsy rate—than conventional mammography (Berg, 2009).  
MRI has a high sensitivity to glandular breast tissue, and because of its sensitivity 
to DBT and its specificity, it enables clearer imaging of DBT for breast cancer detection 
(Karellas and Vedantham, 2008). The way MRI images breast tissue is based on physics. 
Scientists suggest that normal breast tissues and malignant breast tissues must be 
separated on acquisition of breast images (Hendricks, 2007). Scientists supported their 
argument on the longitudinal relaxation times (T1), the transverse relaxation times (T2), 
and the spin densities of the hydrogen protons that are abundant in water molecules in the 
human body (Hendricks, 2007). Cancerous tissues were found to have higher T1 and T2 
values than normal tissues (Hendricks, 2007). Because MRI can distinguish between 





breast imaging community (Hendricks, 2007). However, MRI alone can lead to false 
positives. But if it is used with mammography for breast screening in DBT, the gap can 
be minimized, and women with DBT could have early detection of breast cancer, 
followed by early treatment.  
Purpose of the Study 
The purpose of this study was to determine to what extent conventional 
mammograms can miss breast cancer in women with DBT and to determine if an adjunct 
method of imaging DBT might detect breast cancers missed by mammography alone. 
The paradigm was the mixed-methods research model, with the quantitative phase done 
first to test the theory that conventional mammograms can miss cancers in DBT. The 
qualitative approach was then used to obtain data provide responses based on the lived 
experiences of women with DBT. The mixed-method approach was used to broaden 
understandings of the research topic by integrating the quantitative and qualitative 
research strands (Creswell, 2009).  
Research Questions 
The following two research questions guided this study: 
Research Question 1 (quantitative): Should MRI be used for screening women 
with DBT as an adjunct to conventional mammography? 
H0: MRI technique for screening women with DBT should be used as an 





H1: MRI technique for screening women with DBT should not be used as an 
adjunct to conventional mammography. 
Research Question 2 (qqualitative): What are the lived experiences of women 
with breast cancer in DBT prior to and after the breast cancer diagnosis? 
Subquestion 1: What circumstances prompted the need to screen for breast 
cancer?  
Subquestion 2: How were the lives of women with a DBT cancer diagnosis 
impacted from the initial breast cancer screening to the final breast cancer 
diagnosis? 
Subquestion 3: How does having DBT with a cancer diagnosis affect the lives 
of women with the disease? 
Subquestion 4: How might the addition of an adjunct imaging method, MRI, 
to the existing method help to bring a deeper understanding and a definite 
diagnosis of cancer in DBT? 
Conceptual Framework  
The theoretical framework supporting this study consisted of von Bertalanffy’s 
(1968) general systems theory, Miller’s (1978) living systems theory, and the theory of 
intelligent medical diagnosis (Jones, Lowe, & Harrison 2002). Von Bertalanffy argued 
that subsystems interrelate and depend on each other for the creation, mutation, process, 
and survival of the system. In the body, subsystems support each other in order for the 





may fail, causing the body to die. If breast cancer is not diagnosed and treated in the early 
stages, it can metastasize and spread to other parts of the body, causing other subsystems 
to fail, resulting in death. When cancer is present, subsystems cannot function 
holistically.  
Subsystems within the human body must work together for the individual to be 
healthy. If MRI or ultrasonography is used in addition to conventional mammogram, a 
diagnosis of cancer can be made at the screening phase; intervention and treatment could   
follow. Treatment could commence immediately, which can bring social change at the 
individual and community levels.  
Miller’s (1978) living systems theory presents the supra system of a component 
and the need for all subsystems within the supra system to be integrated and to adjust 
within their environments for the survival of the supra system (Miller, 1978). Similarly, 
all subsystems within the human body are dependent on each other for the survival of the 
human. When there are untreated diseases in the human supra system, then the supra 
system will fail. In the case of breast cancer screening in DBT, if the cancer is detected 
early, it can be treated early? And thus allow subsystems to be integrated and to adjust for 
human survival.  
This study was also informed by the theory of intelligent medical diagnosis (Jones 
et al., 2002). It permits the use of all knowledge and information that is available from a 





(Jones et al., 2002). As in this study, early detection of breast cancer in DBT can lead to 
early treatment for the disease.  
General systems theory and living systems theory have a direct relationship to the 
study. All systems within the human facilitate the proper function of the body, but when 
breast cancer is not detected, this can cause disruption in the harmonious flow and 
integration of subsystems, which will cause the holistic supra system to fail. In the life 
process, life can end if breast cancer is undetected or if it is detected too late. If breast 
cancer is not detected in DBT, then subsystems cannot adjust to compensate for 
malfunction, a fractured system results, which can lead to a breakdown and 
nonregeneration of the holistic system (Miller, 1978; von Bertalanffy, 1968). In addition, 
the theory of intelligent medical diagnosis has a direct relationship with the study, as it 
allows for vague evidence, when analyzed, contributing to an understanding of the topic. 
Nature of the Study 
This study used mixed methods with a sequential explanatory strategy (Creswell, 
2009). I chose this methodology because health care issues are complex, and neither the 
quantitative nor the qualitative approach alone has the scope to explore, synthesize, 
analyze, or provide support to the research hypothesis that MRI can be used as an adjunct 
to conventional mammography to screen DBT for breast cancer (Creswell, 2009).  
The quantitative method was used in the first phase to guide the study, to explore, 
test, explain, and make predictions about the research phenomenon (Simon & Goes, 





data to amplify the topic (Creswell, 2009). The results of both paradigms were integrated 
to present the findings (Creswell, 2009; Simon & Goes, 2013).  
Quantitative data were used to test the hypothesis and to learn whether an adjunct 
imaging method was needed for DBT because conventional mammography has a low 
sensitivity to glandular tissues and can miss cancer in glandular breast tissue. Statistical 
techniques were used to determine if the hypothesis was accepted or rejected. This 
research method also includes a narrow angle to show the effectiveness of conventional 
mammography, sonograms, and MRI to image DBT. Sonograms and MRI techniques 
were reviewed to show which imaging technique is effective or has a high sensitivity to 
DBT. Data for the quantitative portion were collected from national registries, such as the 
CDC, NCI, and ACR. Data were analyzed to determine if the statistical connection 
showed a need for an adjunct imaging method to image DBT for this specific population 
of women.  
In Phase 2, I asked 20 women with DBT who had conventional mammograms, 
sonograms, and MRI for breast cancer screening to respond to a questionnaire. An e-mail 
explained the purpose of the study and the intended use of the results, including 
providing them to participants as an incentive to participate. The women surveyed for the 
study were selected from a small suburb in California. I will discuss the details of data 
collection in Chapter 3; synthesis and analysis appear in Chapter 4.  
Definitions of Terms 





BRCA: Term used to describe breast cancer susceptibility genes. A BRCA gene 
test can be done by a blood test to determine if one is a carrier of the inherited BRCA 
gene (Mayo Clinic, 2013).  
BI-RADS: Term used to quantitatively express densities of breast tissue (ACR, 
2013).  
Conventional mammography: A diagnostic examination that used radiation to 
image breast tissue and to screen for breast cancer (Radiologyinfo.org, 2013).  
Dense breast tissue: Glandular breast tissue (Susan G. Komen, 2013). 
False positive: General findings that are positive for a broad spectrum of a 
specific disease that cannot be determined as malignant or benign without further 
investigation (Elmore et al., 2013). 
MRI: Magnetic resonance imaging is a diagnostic imaging method that does not 
use ionizing radiation, but uses a magnetic field, hydrogen protons in the body, 
radiofrequency pulses, and a powerful computer to produce cross sectional images of the 
body (WebMD, 2013).  
Ultrasonography: A process that uses sound waves to reveal images of bodily 
tissue (WebMD, 2013).  
Assumptions 
This study was based on several assumptions: 
1. MRI can be used to image breast tissue, but usually only for high-risk 





2. Some health care insurance providers oppose MRI for screening for DBT 
because of the cost of the test. 
3. MRI is not used to image DBT for breast cancer screening because of cost. 
4. Not all states require radiologists and physicians to notify women if there is a 
finding of DBT. 
5. Some physicians believe that MRI produces false positive results and might 
cause patients with DBT to experience increased anxiety.  
6. An MRI can be uncomfortable because of claustrophobia or discomfort during 
the long testing procedure. 
7. Only physicians from California, Connecticut, New York, Texas, and Virginia 
are mandated to notify patients of the results of conventional mammography 
for DBT results (Advance for Imaging & Radiation Oncology, 2013). 
Scope and Delimitations 
The scope of the study was to learn the specificity of ultrasonography and MRI in 
relation to the recommended method of conventional mammography. I collected data 
from cancer registries at the ACS, ACR, and CDC and analyzed them to determine if 
there is a gap in imaging modalities when imaging DBT in breast cancer screening. 
SurveyMonkey was used to collect data from an e-mailed Internet interview (Creswell, 
2009). SurveyMonkey is a web-based data collection tool that has been used since 1999, 
has been field tested, and has proven to be effective. To establish validity of 





dependability, and conformability (Creswell, 2009, p. 149; Simon & Goes, 2013, p. 1; 
Trochim & Donnelly, 2007). I checked reliability for the qualitative data collection using 
SurveyMonkey using member checking (Simon & Goes, 2013). Data provided 
information about the timeline of the dense breast diagnosis and other imaging options 
that were provided. The diagnosis for each imaging modality for DBT was analyzed, 
compared, and contrasted. 
Qualitative data were collected over 2 weeks from women in a specific region 
who had been diagnosed with DBT and who responded to open-ended questions to gain a 
detailed response to their experiences with alternative methods of screening. They were 
asked to describe (a) the imaging method used for breast screening, (b) cancer diagnosis 
or not, (c) whether additional imaging techniques were used to further test if the result of 
breast cancer screening was abnormal or inconclusive because of DBT, and (d) when 
treatment commenced after a cancer diagnosis or prognosis of the disease. 
Limitations  
The following were considerations relative to the outcomes: 
1. The study might have been hindered by time and cost constraints, as both 
numeric and text data were collected. Since the study is complete, would you 
know the answer to this? 
2. Weight of the methodology paradigm might determine if the research would 
depend more on quantitative or qualitative data. Since the study is complete, 





3. What would be the right point in data collection to mix results of collection, 
analysis, or interpretation? (Creswell, 2009). It is not clear how this would be 
a weakness. 
4. The number of women with DBT in the region did not provide enough 
participants for the study. 
5. Some women with DBT choose not have an MRI and have a sonogram 
instead. This decision may yield a smaller sample, which might not be 
generalizable or applicable to a larger population. 
6. MRI can produce false positive results, a diagnosis that could lead to anxiety.  
Significance of the Study 
One in eight women in the United States will die from breast cancer (NCI, 2012). 
Although the United States has the best equipment for diagnosis, highly qualified 
radiologists, physicians, hospitals, and medical clinics, breast cancer can be missed in 
DBT with the use of only conventional mammography for breast cancer screening (Boyd 
et al., 2007). However, MRI is a newer imaging modality for breast cancer diagnosis, and 
many physicians do not trust the results of this advanced technique because of the 
number of false positive findings. MRI, however, has a higher sensitivity for breast 
cancer detection in DBT, and the use of this technique can complement conventional 
mammography for breast cancer evaluation.  
The literature reveals that conventional mammography remains the only method 





glandular tissue and can miss cancer in DBT (Boyd et al., 2007/2010). There is a need for 
an adjunct imaging method that has a higher sensitivity to glandular tissues (Berg, 2009). 
Ultrasonography has been used to image DBT, but the false positives remain very high 
(Berg, et al. 2008; Padilla et al. 2013). False positive results from DBT using 
ultrasonography have resulted in a higher number of breast biopsies that were benign 
(Berg, et al, 2008; Padilla et al. 2013). MRI has produced accurate results for dense 
breast imaging but currently has been used only for high-risk breast cancer patients.  
The current trend in breast screening is conventional mammograms, and this 
technique is used nationally to screen women for breast cancer. (ACS, 2013). In 
California, Connecticut, New York, Texas, and Virginia, radiologists and physicians are 
required to inform patients if they have DBT (ADVANCE for Imaging & Radiation 
Oncology, 2013). DBT is measured using the six-category system initiated by the ACR 
called BIRADS. There are six levels of breast density measurements: 0, <10%, 10-25%, 
26-50%, 51-75%, and >75% (Yaffe, 2008). Findings of DBT must be disclosed to the 
patient. Usually, the physician recommends that additional imaging is needed to see 
inside the DBT. At this stage, though, it is the patient’s decision to explore additional 
options for dense breast imaging. If the patient is not familiar with options for dense 
breast imaging and physicians believe that a sonogram is a better choice because of the 
cost factor, then the patient may follow that recommendation. MRI, however, has 





conventional mammogram, it can produce accurate results for breast cancer diagnosis in 
DBT (Berg, 2009). 
Summary 
Mammography is the standard tool used for breast cancer screening, and although 
it is effective for routine mammography, it has a low sensitivity for DBT and can miss 
some cancers (Giuliano & Giuliano, 2012). Ultrasonography is used as an adjunct to 
conventional mammography, but this method yields more false positives for breast cancer 
anomalies than conventional mammography. Imaging of DBT utilizing MRI has yielded 
accurate findings for breast cancer among the group of women with DBT and produces a 
lower number of false positive cases. MRI has a higher sensitivity for imaging DBT 
because its unique characteristics enable it to reveal the matter inside dense tissue. Added 
to conventional mammography, MRI will result in more accurate diagnoses of breast 
cancer. 
Chapter 2 is a review of professional and peer-reviewed literature on breast cancer 
screening, including comparisons among conventional mammography, ultrasonography, 
MRI, and their application and results. In Chapter 3 the methodology that was used to 
conduct the study is covered. Chapter 4 presented the results of the study and Chapter 5 
presented an interpretation of the study, limiting factors, recommendations for future 





Chapter 2: Literature Review 
Introduction 
The purpose of this study was to determine to what extent conventional 
mammograms can miss breast cancer in women with DBT and to determine if an adjunct 
method of imaging DBT might detect breast cancers missed by mammography alone. 
The purpose of this chapter was to learn what research has shown about the sensitivity of 
MRI and ultrasonography to cancer in DBT. Although conventional mammography is 
effective for routine breast cancer screening, it has a low sensitivity to DBT and can 
therefore miss cancers in these tissues (ACR, 2012); in the United States, the figure is 
about 20%. 
The literature review consists of four sections: 
1. Section 1presents peer-reviewed material on an historical overview of options 
for dense breast tissue imaging.  
2. Section 2 is a discussion of the theoretical foundation of the study: general 
systems theory, living systems theories, and the theory of intelligent medical 
diagnosis. It draws a parallel to the hypothesis that an adjunct imaging option 
can be of benefit in imaging dense breast tissue.  






4. Section 4 explores peer-reviewed material on the sensitivity or lack of 
sensitivity of conventional mammography, ultrasonography, and MRI 
imaging methods for cancer detection in glandular breast tissues.  
Literature Search Strategy 
Most sources in this chapter are from the American College of Radiology (ACR), 
the American Cancer Society (ACS), the National Cancer Institute (NCI), and the Susan 
G. Komen Foundation. Additional sources were obtained through the following  
databases: EBSCO, MEDLINE, CINAHL, PubMed, Science Direct,Cochrane Database 
of Systemic Reviews, and ProQuest Dissertations & Theses. The following keywords 
used to search the literature: DBT, imaging options, MRI as a screening tool, 
uultrasonography as a glandular tissue screening tool, adjunct imaging screening tools, 
sensitivity of conventional mammography to screen for DBT, sensitivity of 
ultrasonography to screen for DBT, dense breast measurement, BI-RADS, general 
systems theory, and living systems theory.  
Theoretical Foundation 
System theory asserts that elements within an entire system are dependent upon 
each other for the system to function properly (von Bertalanffy, 1968). When a 
subsystem within the general system cannot function or fails, this can cause the holistic 
system to stop its functionality (Miller, 1974; von Bertalanffy, 1968). Thus, since the 
failure of one system in the human body can cause the organism to fail, this theory has 





living organism and the integration of its parts for sustainability, while general systems 
theory (GST) explains adaptation of networks within a complex system. These theories 
are relevant to this study because DBT is part of the holistic human body, and if cancer is 
found and treated, then the human body can achieve sustainability. Cancer researchers 
apply GST and LST to their work because these theories can explain that if a disease is 
detected early, it can be treated early and prevent systemic morbidity (Rosenfeld & 
Kaptanovic, 2008). Additionally, this study is guided by the theory of intelligent medical 
diagnosis (Jones et al., 2002). The theory of intelligent medical diagnosis is to understand 
the disrupted homeostasis of all aspects of a particular phenomenon and combine a 
variety of options for a robust solution (Jones et al., 2002; Koutsojannis & 
Hatzilygeroudis, 2006). The theory of intelligent medical diagnosis is relevant to the 
study because cancer in DBT can interrupt the normal function of the human body, and if 
not found in the early stages, can disrupt the normal function of the body.  
The ACS promotes screening for early detection of breast cancer by advising 
those who are at a high risk for breast cancer to seek MRI breast screening, as 
conventional mammography has limitations for detecting cancer in DBT (2013). If there 
is early detection of the disease, early treatment options can be pursued. As suggested by 
the social change theories of von Bertalanffy and Miller, holistic systems are comprised 
of multiple subsystems that integrate to form the whole system and that the system may 
die if one subsystem fails (von Bertalanffy, 1968). Similarly, the human body may die if 





that if a subsystem within the general systems fails, but is repaired, then the general 
system could continue to function.  
GST application in nursing practice (Glennister, 2011) showed the importance of 
sub disciplines within the holistic nursing practice and its position in the community. 
Glennister, (2011), and stated that because nursing covers a multitude of subsystems for 
its functionality, a failure of one subsystem can cause the holistic system to cease to 
function. The application of GST is well demonstrated in system thinkers such as 
Henning (2011), who argued that for human beings to achieve their goals, a human 
network support must be available. However, if there is a failed mental health subsystem 
in the support network, the goal will not be achieved and the whole system will fail.  
LST application to combat models for the army (Crawford & Naval Post Graduate 
School, 1981), articulated the need to integrate more organization into the existing 
framework. The author stated that the combat model is dependent on the existence and 
integration of all levels of personnel, peer and subsystems, for a robust combat model. 
Riss (2012) connected LST with migration and stated that migration occurs because of 
the malfunction of the status quo from which interconnectivity arises. Riss (2012) also 
stated that migration causes reproducibility, which can create a new living system in a 
different environment. Similarly, GST and LST are frameworks that helped to guide and 





Dense Breast Tissue Imaging Options 
The ACR (2012) reported that about 80% of women have DBT. Conventional 
mammography has been the sole method to screen women for breast cancer; however, 
this method can miss cancers are in DBT (Berg, 2009). Imaging methods such as 
ultrasound  and MRI have proven to detect cancers in DBT, but these methods are not 
used for routine screening for the dense breast population (ACS, 2012; ACR, 2012; Berg, 
2011).  
Conventional Mammography 
Although breast X-ray examinations were done prior to 1969, it was not until 
1969 that that dedicated machines were developed for breast cancer screening (ACS, 
2012). Seven years later, mammography became the customary method to screen for 
breast cancer (ACS, 2012). In addition, the Mammography Quality Standards Act 
(MQSA) was passed by Congress in 1992, an act that mandated that operators of 
mammography machines be well trained to operate the equipment, the machines 
regularly updated, and results of tests communicated to patients (FDA, 2012). 
Mammography has been the standard for breast cancer screening since 1969 (ACS, 
2012). If anomalies were seen on breast screening radiographs, diagnostic mammograms 
were then done on concentrated areas of the breast, (ACS, 2012).  
There was one major setback for diagnostic mammograms with a breast cancer 
diagnosis. Although the FDA required minimizing the radiation dose, an additional 





Other setbacks for mammograms and diagnostic mammograms were accuracy of imaging 
equipment, expertise of the interpretation radiologist, and the expertise of the 
technologist. However, mammography was the sole imaging method for breast cancer 
screening despite an increased radiation dose to the patient, and any abnormal breast 
finding would result in a repeat mammogram (Breast Cancer.Org, 2012). The ACS 
reported that in 1969 when breast screening began, abnormal mammograms were not 
attributed to DBT, and abnormal breast tissue findings were followed by additional 
mammograms (2012). This practice increased the radiation load and still could not 
provide accurate images in DBT. 
The ACS recognizes that DBT is not an abnormal finding for breast screening, 
especially in asymptomatic women, younger women, and older women, but there is no 
consensus on what other imaging examinations should be used in addition to a 
conventional mammogram (2012). DBT is problematic because mammography has a low 
sensitivity to dense tissues and can miss cancers in them (Berg, 2011). Cancers can hide 
and grow in DBT, and if this anomaly is not found using other imaging techniques with 
higher sensitivity to DBT, there is a high probability that breast cancer can be missed, 
remain untreated, metastasize, and spread to other parts of the body (Berg, 2011).  
The ACR recommends that women should have a mammogram beginning at age 
40 for breast cancer detection, but does not have recommendations for screening for DBT 
(2012), even though in the United States, 40% of women who had mammograms have 





80% have a mixture of fatty and DBT (ACR, 2012). The Mayo Clinic (2013) reported in 
a recent study that 75% of breast cancers in DBT are undetected by mammographic 
screening. Dense breast tissues are very bright in mammograms, and abnormalities in 
DBT appear bright as well, which makes diagnosis difficult. Many women have DBT: 
those who are younger, who have low hormone levels, who have borne children, are in 
menopause, or who are pregnant (ACS, 2012). Although a radiologist may tell women 
they have DBT, often there is no recommendation for what the women should do next.  
The CDC recommends screening for breast cancer in three ways: a mammogram, 
a clinical breast exam (CBE), and a breast self-exam (2012). However, the CDC says 
these screening methods must be discussed with a physician and does not recommend 
other imaging options. The CDC (2012) reported that each year 350,000 people will have 
a cancer diagnosis, and 100,000 will die from the cancer. Healthy People 2020 observed 
that although the target rate for breast cancer screening is 81%, breast cancer screening is 
only 72.4%. Women are not being screened for breast cancer at recommended rates, 
which makes it difficult to know about the population with DBT. 
 Ultrasonography for Imaging Dense Breast Tissue 
When ultrasound techniques were introduced for breast imaging in 1951, it was 
embraced by the medical community because the technique does not use radiation for 
imaging. Rather it differentiates between cysts and masses for surgical invasive breast 
procedures (Medscape, 2012). In ultrasound imaging, a transducer sends out high 





internal organs such as blood vessels, fluids, and tissues. These echoes are measured by a 
specialized computer for a real-time image.  
While ultrasound techniques evaluate obvious anomalies such as lumps, breast 
pain, postsurgical breast tissue, and breasts that have had an abnormal mammogram 
finding, ultrasonic techniques are limited for breast cancer screening. Factors such as 
operator expertise and quality of equipment used for using ultrasound to scan breasts for 
breast cancer screening are major considerations. Sabih (2013) stated that using hand-
held transducers for breast cancer screening and even basic breast screening is inadequate 
for breast imaging. The American College of Radiology Imaging Network (ACRIN) 
reported that breast screening can only be accurately done if ultrasound machines are 
automated; since automated ultrasound machines have higher resolution that produces 
more accurate findings because of its inherent near-field resolution (Sabih, 2013).  
In a 2013 publication by the ACRIN, Berg stated that using sonography for DBT 
provided results that showed small non palpable tumors in DBT that were not seen on 
conventional mammograms. Berg further stated the benefit of sonography use to detect 
anomalies in DBT was not 100% clear. Finding small non palpable tumors during 
mammogram might create bias in the sonography findings. A larger study provided 
results from data published by Kelly et al. (2010) in which 4,419 women were scanned 
using the automated whole breast ultrasound (AWBU). Results from this study showed 
that using the AWBU yielded significant cancer detection in DBT when this technique 





be used solely for DBT screening. Berg (2008) had a similar view that ultrasound to 
image DBT has setbacks, including inconsistent proficiency of the operators and lack of 
standardized protocols.  
The ACR implemented a standardized process called Breast Imaging Reporting 
and Data Systems (BI-RADS), a classification used as evaluation criteria (Nothacker, 
2009). The BI-RADS standard process yielded occult tumors and increased the number 
of unnecessary biopsies. Berg (2008) stated that when ultrasound was added for dense 
breast screening with mammography, cancer identification increased to 1.1 to 7.2 per 
1,000 high risk women, but Berg concluded that ultrasound use increases the number of 
false positives. The ACS (2012) recommends that high-risk women have additional 
imaging for breast cancer but does not recommend ultrasound for women with DBT. 
However, the ACS reported that in addition to conventional mammography, ultrasound 
techniques can produce benefits if there is a DBT finding on a screening mammogram. 
They concluded, however, that the quality of an ultrasound of DBT depends on the skill 
of the operator.  
The NCI (2012) stated that ultrasound can detect breast cancer in 3.7 cases per 
1,000 women who are screened after the second and third annual breast screen. However, 
the NCI suggested that there are a high number of false positive and false negative 
findings using this technique and does not recommend it be used to screen for breast 
cancer (NCI, 2012). The Susan G. Komen foundation reported in 2013 that physicians do 





cancer but that ultrasound techniques were being studied to use with conventional 
mammogram. 
The U.S. Food and Drug Administration approved the first ultrasound machine to 
image DBT in September 2012 (FDA, 2012). Because 226,870 women would be 
diagnosed with breast cancer in 2012, and 38,510 would die from the disease, the agency 
recognized the need for another imaging option for DBT (FDA, 2012). The FDA 
approved the first Automated Breast Ultrasound System (ABUS) to image DBT using a 
technique that was faster, more efficient, and surpassed the images produced by other 
ultrasound machines. This technique was approved for use in patients with DBT who had 
had negative conventional mammograms. However, the ABUS system has a specific 
exclusion criterion for its application: It does not include women who had prior clinical 
breast interventions such as surgeries, were pregnant, or were breast feeding, because 
these factors can alter the appearance of breast tissue (FDA, 2012). In addition, the use of 
the ABUS system must follow the ACS’s BI-RADS categories for density and 
composition as shown below: 
1. BI-RADS 1: The breast is almost entirely fat (<25% glandular). 
2. BI-RADS 2: There are scattered fibro glandular densities (approximately 25-
50% glandular). 
3. BI-RADS 3: The breast tissue is heterogeneously dense, which could obscure 





4. BI-RADS 4: The breast tissue is extremely dense. This may lower the 
sensitivity of mammography (>75% glandular. (ACR, 2012, p. 5; FDA, 2012) 
In an analysis of 100,000 women with DBT, there were many false positive 
results, and some patients were referred for additional imaging or for unnecessary 
workups (FDA, 2012; Kloten et al., 2013). MRI has a high sensitivity for breast cancer 
detection, but it is currently used for high risk patients and not for DBT screening (Berg, 
2011; van Goethem et al., 2009). 
MRI Use for Dense Breast Tissue 
 MRI uses a “strong magnetic field, hydrogen protons in the water of the body, 
radio waves, surface coil, and a specialized computer to image soft tissues and organs 
inside the human body” (Frank, 2011, p. 330). The physics of this technique allows to 
clearly see inside dense breast tissue where anomalies can remain hidden and metastasize 
if they are cancerous and remain undetected (RSNA, 2013). This technique can also 
produce 3-dimensional, high resolution images which can be reformatted to any 
orthogonal plane where the breast anatomy and anomaly can be best visualized (RSNA, 
2013). Additionally, this technique does not use ionizing radiation, which can place the 
patient at risk of dangerous radiation exposure if additional imaging is needed (WebMD, 
2013). MRI imaging is noninvasive, but an MRI examination of the breast may be less 
tolerable to the patient, as it may take up to 30 minutes. Additionally, certain metal in the 
body automatically excludes MRI examination due to heating, torque, and potential 





MRI was introduced for clinical use in late 1970, but it was not until 1991 that it 
was approved by the FDA for breast imaging (Imaginis, 2013). In the 1980s, researchers 
further studied breast imaging and discovered MRI techniques could differentiate 
between normal and abnormal breast tissue (Hendrick, 2008). This MRI technique was a 
breakthrough for imaging breast cancer, and the added incentive was that the technique 
was noninvasive. MRI of the breast can be used to detect anomalies in unilateral or 
bilateral breasts, the chest wall, axillary regions and surrounding areas of the chest (ACR, 
2013). In addition, MRI can evaluate questionable anomalies identified on mammograms 
and ultrasound exams (Radiologyinfo, 2013). The approval of MRI was embraced by the 
breast cancer community due to its sensitivity to breast anomalies detected in a 
mammographic examination. Although the use of breast imaging techniques such as 
mammograms and ultrasound are still recommended, renowned cancer registries such as 
the ACS (2012) and ACR (2013) stated that MRI excels at imaging dense breast tissue 
because this technique has a very high sensitivity to dense breast tissue.  
MRI is also useful to image younger women that are not predisposed to breast 
cancer, but have dense breast tissue (Berg, 2009). This group is asymptomatic and not 
predisposed to breast cancer, that is, no family history of breast cancer, and therefore 
cancer can be undiagnosed. This group falls under the 40 year old group, which is the age 
that agencies and organizations such the ACS, ACR and CDC recommended that women 
should be screened for breast cancer (ACR, 2013; ACS, 2012; CDC 2012). Also women 





dense breast tissue (ACS, 2013). Cancers in DBT for this group that can be missed by 
mammogram screening for breast cancer, but MRI provides very clear images of 
anomalies that can see inside dense breast tissues (Hendrick, 2008). In addition to breast 
imaging, MRI is widely used to image women with augmented breasts, surgery planning, 
both implants and post-surgery (Berg, 2009). However, MRI examinations also led to 
false positive findings (Elmore et al., 2013; Imaginis, 2013), and as a result, ACS does 
not recommend an MRI for breast screening, as it may lead to unnecessary invasive 
breast procedures. But when MRI is compared to conventional mammogram and 
ultrasonography for breast cancer screening, false positive findings are fewer. Therefore, 
the literature showed that there is a significant benefit to use MRI for breast imaging. 
However, breast cancer agencies and organizations do not provide guidelines that MRI 
can be used to screen asymptomatic women with DBT.   
Scholarly Literature 
 In a 2012 report, the ACR recommended and applauded the use of conventional 
mammography for breast cancer screening and suggested that women who are 
predisposed to breast cancer because they carried the BRCA gene or whose close 
relatives have a breast cancer history should seek supplemental breast imaging (ACR, 
2012; ITN, 2013). However, the ACR did not provide recommendations for screening of 
DBT and offered the same recommendation in 2013. The ACR (2012) stated that 
although MRI can detect cancers in dense tissue that cannot be seen on a mammogram, 





ACR (2012) suggested that if breast cancer is detected early, treatment can be done at the 
early stages after cancer detection, but the ACR does not provide recommendation for 
asymptomatic women with DBT.    
Likewise, the CDC has not provided a recommendation that a diagnostic imaging 
technique should be used to screen women with DBT (CDC, 2011). What the CDC 
recommended is that DBT can be screened using scintimammography (2011), an imaging 
technique where a radioactive tracer is injected intravenously and images of the breast 
taken to show if the tracer attaches itself to the cancer cells in the breast tissue (ACS, 
2013). This technique is used to image DBT for high risk patients, but it is not 
recommended for screening the dense breast population (CDC, 2011). Like the ACR and 
ACS, the CDC does not recommend a screening method for DBT. Although the ACR, 
the ACS, and the CDC are advocates for early breast cancer screening that can lead to 
early treatment of the disease, they do not recommend imaging protocols for DBT.  
The ACS recommended that women 40 years and older should have a screening 
mammogram every year, and women between 20 – 30 years of age should a clinical 
breast exam every three years (ACS, 2014). In addition, the ACS recommended against 
using MRI as a screening tool to screen women for breast cancer whose lifetime risk of 
breast cancer is less than 15% (ACS, 2014).  
Similarly, the NCI reported that other imaging technologies are being developed 
to detect tumors, but did not have recommendations for imaging DBT for screening 





which is a marker to develop breast cancer, does not indicate increase mortality rates for 
breast cancer. The NCI stated that more research is needed to recommend MRI as a 
screening tool for asymptomatic women with DBT (NCI, 2012).  
The FDA has recommended diagnostic imaging options including 
ultrasonography, scintimammography, thermography, and digital breast tomosynthesis, 
but the FDA has not recommended a screening tool for DBT (NCI, 2011, p. 22). 
Although the FDA a regulatory amendment that women in all states should be informed 
if there is a DBT finding, they do not provide a recommendation for additional screening 
for asymptomatic women with DBT (FDA, 2013).  
Some state government officials have declared that physicians must inform their 
patients if they find DBT during a screening mammogram. Senator Joe Simitian of 
California, Senator Jeremy Ring of Florida, Governor Rick Perry of Texas, and 
government officials from Alabama, California, Connecticut, Hawaii, Indiana, Maryland, 
New York, North Carolina, Nevada, Oregon, Tennessee, Texas and Virginia have 
advocated that physicians must inform their patients if there is a dense breast finding 
(ACR, 2013; Simitian, 2012; Florida Senator, 2013; Henda’s Law, 2012; Diagnostic 
Imaging, 2012). In states such as Utah, Maine, and Illinois, it is optional for physicians to 
inform their patients if they find DBT during a screening mammogram (ACR, 2013). 
Massachusetts, Michigan, New Jersey, Michigan, New Jersey, Ohio and Pennsylvania are 
states that have pending legislation to inform patients if there was a DBT finding during a 





In a 2012 article, the NCI reported that 2,800 women with DBT were screened for 
breast cancer. Data obtained from 612 women showed an increase in cancer detection 
using ultrasonography, but this finding led to breast biopsies that yielded a small number 
of positive breast cancer findings (NCI, 2012). The same group of 2800 women with 
DBT was screened using MRI. Although MRI yielded a higher number of positive breast 
cancer cases more than mammography and ultrasonography, the NCI stated that breast 
density does not influence breast cancer mortality (NCI, 2013).  
The Cochrane Collaboration provides health information to evaluate the 
possibility of a risk or advantages of a specific condition. The Cochrane Database of 
Systemic Reviews reported that screening mammograms can lead to 30% over diagnosis 
and overtreatment, and it remains unclear if screening mammograms benefit or harm 
women (Cochrane Summaries, 2011). The Cochrane Collaboration has also not issued 
recommendations for DBT screening. The United States Preventive Services Task Force 
(USPSTF), an independent organization that studies and recommends screening practices 
to health systems, suggested that women should be screened for breast cancer biannually 
from ages 50 to 74 years of age but not routinely screened from 40 to 49 because there is 
not enough research data to warrant the need for screening (2009). Further, the USPSTF 
suggested that it should be the choice of women to decide when routine screening for 






 The following states have laws that require physicians to inform patients of DBT 
findings: Alabama, California, Connecticut, Hawaii, Indiana, Maryland, New York, 
North Carolina, Nevada, Oregon, Tennessee, Texas and Virginia.  However, they but do 
not mandate a referral for this population for additional imaging, such as an MRI or 
ultrasound, only that other imaging options be available (ACR, 2013; Brower, 2013). 
Other imaging options are available for women at high risk for breast cancer, but not for 
asymptomatic, women with DBT (Wood et al., 2013).  
Gap in the Literature 
Further breast cancer screening for DBT stops after there is a DBT finding, 
according to the Susan G. Komen Foundation (2013). A strong advocate for breast cancer 
prevention and treatment, Komen states that there is not an imaging method to screen the 
dense breast population and that physicians do not normally use breast density numbers 
to make a breast cancer diagnosis. However, since 2009, the Breast Density Inform law 
in the United States has required that physicians inform women of their breast density 
numbers. Subsequently, 11 states require physicians to inform women of their breast 
densities (Pushkin, 2013). Although this is a positive step for women with DBT, there is 
not a follow-up after the finding. The ACR, ACS, and the NCI have also reported the 
need for an adjunct imaging method to complement conventional mammography for 
DBT, but MRI is used only for women in the high-risk population, those with a history of 
breast cancer, a strong family history of breast cancer, atypical hyperplasia, and DBT 





MRI and Sonogram for Dense Breast Tissue Imaging 
Ultrasound methods can detect 30% more cancer than mammograms 
(AuntMinnie, 2010) and is useful for identifying breast anomalies such as protuberance, 
swelling, nipple discharge, fluid-filled cysts, and for differentiating between solid and 
fluid-filled masses (RSNA, 2013). Ultrasound imaging for DBT can be used with 
conventional mammograms as an adjunct for breast screening, but both ultrasound 
imaging and conventional imaging can miss 22% of cancers in DBT, but MRI has shown 
a high sensitivity to image DBT (Radiologyinformation.org, 2013). Currently, MRI is not 
used for breast cancer screening except for high-risk cases, although it has yielded more 
breast cancer findings.  
Literature Related to Research Methods 
A mixed methods design was used for this investigation of whether there is a need 
for an additional method to image women with DBT. The quantitative approach was also 
used to test the hypothesis, using statistics from the CDC, ACR, and ACS. Secondary 
data was collected from those cancer registries to determine whether a method is needed 
as an adjunct to conventional mammography. This quantitative data was analyzed to 
inform the qualitative phase of the study (Creswell, 2009).  
The second phase was a qualitative approach that builds upon the first. 
Descriptive statistics were collected from answers women give about the methods used to 
image their DBT (Simon & Goes, 2013). Answers provided richer data about the 






In this chapter, I presented a review of literature published within the past 5 years 
that asserts that conventional mammography can miss cancer in DBT because this 
imaging method has a low sensitivity to DBT. Ultrasonography to image DBT was also 
reviewed as was the sensitivity of MRI for breast cancer screening. The purpose of the 
literature review was to highlight the sensitivity of ultrasonography and MRI techniques 
as screening methods for DBT.  
Chapter 3 describes the method I followed to collect secondary data from cancer 
registries such as the CDC, ACS, ACR, and NCI to support whether an adjunct imaging 
tool is needed in conjunction with conventional mammography to image DBT. In 
addition, it describes how I collected qualitative data from a small group of women in 
San Jose, California, who responded to survey about their experiences with breast 





Chapter 3: Research Method 
Introduction 
The purpose of this study was to determine to what extent conventional 
mammograms can miss breast cancer in women with DBT and to determine if an adjunct 
method of imaging DBT might detect breast cancers missed by mammography alone.  
Although the ACS, ACR, and CDC advocate early detection and treatment of 
breast cancer, they do not mandate  imaging options for breast cancer screening for 
women with DBT by. (ACR, 2013; ACS, 2012; CDC, 2013). Because conventional 
mammograms detect less than half of cancers in DBT, many breast cancers are missed 
(Are You Dense? 2013). As a result, there was a need to determine if there is an 
additional  method for screening women in the DBT population.  
Most of the literature in Chapter 2 concluded that mammography should still be 
used, but that an adjunct method with a high sensitivity to detect cancer in glandular 
tissue is needed (Berg, 2009; Susan G. Komen, 2012; Zonderland et al., 2013). For those 
reasons, I explored whether there was a need for ultrasonography and MRI—two 
standard alternatives--following a determination of DBT (Creswell, 2012). A mixed-
methods design was determined to be best suited for this study because they provide 
complementary approaches to learning more about a topic that has both physical and 
emotional aspects. Greene, Caracelli, and Graham (1989) asserted that research is 





Before I collected any data, I submitted a proposal to the Walden University 
Institutional Review Board for approval and was given Approval No. 10-07-14-0078441. 
The first results are from the quantitative strand, which tested whether an adjunct method 
of screening is needed for the 40% of women with DBT. In the second strand, responses 
from women with DBT (which included the imaging methods used for their breast cancer 
diagnosis), illustrated the qualitative or personal effects of their experiences. Creswell 
(2009) emphasized that using both quantitative and qualitative strands of inquiry can 
provide broader insight into a question. Campbell and Fiske (1959), Jick (1959), and 
Plano Clark (2007) also supported the use of the mixed methods design and noted that 
this approach allows for integration of data, which can produce stronger results.  
Quantitative data are important in a mixed-methods explanatory design because 
the data can explain a phenomenon using objective data and analysis. Quantitative 
analysis began with a random, yet systematic sampling of secondary data about breast 
cancer from the following cancer registry databases: ACR, ACS, CDC, the California 
Department of Public Health (CDPH), and the NCI. From that information, I selected 
every 20
th
 person until I had 500 names using G*Power, a power analysis tool used to 
calculate the appropriate number of participants (Faul, Erdfelder, Lang, & Buchner, 
2007). The process also followed recommendations by Creswell and Plano (2011) and 
Rudestam and Newton (2007).  
An introductory e-mail was sent to the selected sample to explain the rationale for 





electronically signed consent from those willing to participate, explained online access, 
and told them the closing date for participation (Creswell & Plano, 2011; Rudestam & 
Newton, 2007). Systematic random sampling can eliminate bias by ensuring everyone in 
the sample population has an equal opportunity to participate and to ensure the results of 
the survey are representative of the population (Creswell & Plano, 2011; Teddlie & 
Tashakkori, 2009). Data collected were synthesized, analyzed, and tested by inferential 
data analysis using ANOVA (Hoare & Hoe, 2013; Norkett, 2013). Results from the 
quantitative strand led to the qualitative strand.  
The qualitative strand was guided by the phenomenological inquiry approach of 
Moustakas (1994), who stated that the goal of phenomenological inquiry is to bring to 
light the lived experiences of persons who have experienced a phenomenon. This 
investigation highlights the lived experiences of women with DBT and the time it took to 
determine if cancer was present when conventional mammography and MRI were used. 
Based on phenomenological philosophers such as Husserl, Kierkegaard, Heidegger, and 
Sartre, I chose a phenomenological approach because the inductive method can gather 
data through interviews to explain lived experiences of participants (Simon & Goes, 
2013). These data bring a deeper explanation of a phenomenon because it comes from 
women who have experienced it (Moustakas, 1994).  
Although the qualitative method could have been the sole research method, I also 
used quantitative data to add objectivity (Creswell & Plano, 2011; Teddlie & Tashakkori, 





together they contribute different avenues of information to the investigation (Rudestam 
& Newton, 2007). The qualitative strand can provide richer data to build upon the 
quantitative strand to help the researcher understand and put findings from the 
quantitative strand into perspective (Creswell & Plano, 2011; Rudestam & Newton, 2007; 
Teddlie & Tashakkori, 2009). Qualitative data include the subjective responses of 
participants that provided their lived experiences (Houghton, Casey, Shaw, & Murphy, 
2013). Frels and Onwuegbuzie (2013) suggested that the researcher has more flexibility 
in the qualitative approach because of the natural environment where data are collected, 
the explicit process, and the open-ended nature of questions for data collection. In 
addition, responses to open-ended questions can yield detailed responses that may lead to 
a deeper understanding of the premise of the research (Frels & Onwuegbuzie, 2013).  
Chapter 3 describes the research design as suggested by Creswell (2009), Plano 
Clark (2007), and Campbell and Fiske (1959) and includes the research design, the role 
of the researcher, the methodology, description of the research instruments to include 
validity and reliability, the data analysis plan, and ethical procedures.  
Research Setting 
The time and place (some natural setting) for the qualitative strand were 
controlled by the participants. I was sensitive to the wishes of the participants and wanted 
them to feel at ease (Simon & Goes, 2012). The aim of the survey was to learn the feeling 
of the population through open-ended questions that gave them time to reflect, think 





Data were collected through telephone interviews, and conversations were recorded with 
participants’ permission. The recordings provided repeated listening time for 
organization, identification of themes, coding, and analysis (Creswell, 2007).  
Research Design and Rationale 
Research Questions 
Research Question 1 (quantitative): Should MRI be used for screening women 
with DBT as an adjunct to conventional mammography? 
 H0: MRI technique for screening women with DBT should be used as an adjunct 
to conventional mammography.  
 H1: MRI technique for screening women with DBT should not be used as an 
adjunct to conventional mammography. 
Research Question 2 (qualitative): What were the lived experiences of women 
with breast cancer in DBT prior to and after the breast cancer diagnosis? 
Sub Question 1: What were the circumstances that prompted the need to screen 
for breast cancer?  
Sub Question 2: How were the lives of women with a DBT cancer diagnosis 
impacted from the initial breast cancer screening to the final breast cancer diagnosis? 
Sub Question 3: How does DBT with a cancer diagnosis affect the lives of women 





Sub Question 4: How can the addition of an adjunct imaging method such as MRI 
to the existing method help to bring a deeper understanding of the need for efficient 
screening methods and a definite diagnosis of cancer in DBT? 
The independent variable was using MRI imaging techniques to screen women 
with DBT. The dependent variable was breast cancer detection for women with DBT.  
Mixed Methods 
The research design was a mixed methods explanatory approach (Creswell & 
Plano Clark, 2008). The quantitative strand was conducted first, and the qualitative strand 
was used to build upon the results of the quantitative strand. Mixed methods research is 
employed when the results of either a single quantitative and qualitative study does not 
provide a complete understanding of the research problem (NIH, 2013). I employed the 
quantitative approach to test the hypothesis with statistical analysis and the qualitative 
method to reveal data that reflect real life experiences of participants (NIH, 2013). 
Boeije, Slagt, and van Wesel (2013) employed mixed methods to study childhood trauma 
and found that the integration of the quantitative and qualitative strands provided 
additional knowledge about their research topic. Boeije et al. (2013) also found that using 
mixed methods allowed them to draw conclusions and make recommendations for 
improvement of the quality of life for their subjects. Heyvaert, Hannes, Maes, and 
Onghena, (2013) also supported the use of the mixed methods design and reported that it 
is useful in health and health-related subjects and can answer research questions in these 





review that analyzed the mixed methods approach revealed “convenience, reproducible, 
and systematic” qualities (p. 532).  
For the quantitative phase, I collected data using systematic random sampling to 
fulfill the equal likelihood chance of selection and randomness for the target population 
(Banerjee & Allen, 2010). The random sample was selected from a potential population 
of 10,000 women, ages 24–74, who had a consecutive mammogram within the past 2 
years, and selection was every 20
th
 person in that population until the number selected for 
the sample was reached (Simon & Goes, 2012). The geometry of data collection can 
generate sufficient power so that results can be applied to the general population. Gay 
and Suskie (as cited in Simon & Goes, 2012) suggested that if a 250 effect-size sample is 
used for a study, results should be applicable to the general population of similar subjects.  
The qualitative phase was purposeful sampling (Moustakas, 1994) because this 
strategy can yield a typical population (Creswell, 2007, p. 125; Moustakas, 1994). The 
phenomenological approach illuminates the research statement because experiences from 
participants can provide a better understanding of a topic through rich data collected 
during interviews. Twenty participants were selected for this portion of the study. 
According to Creswell (2007), a smaller sample allows a researcher to spend more time 
with each participant and potentially glean richer information. Participant data were 
collected from a full service breast imaging center in a specific demographic region of 





breast finding on a mammogram must be reported to the California Department of Public 
Health (CDPH), data for this group were available and accessible.  
I sent a letter of introduction with information about the study and its purpose and 
goal to potential participants. The letter included my contact information, asked if they 
wanted to participate, and asked them to call me if they wanted to be part of the study. 
One week after they responded in the affirmative, I called to confirm their acceptance and 
answer any questions they had. The process continued with informed consent material 
and ethical information. Upon receipt of the signed informed consent, I called again to 
determine the best time for a telephone interview. To eliminate bias, I called those who 
did not respond to confirm that they were not interested in participating, and added their 
responses to the total number of participants. With the permission of the interviewee, I 
recorded their answers, transcribed and coded them to protect identities, and stored the 
information for analysis using NVivo. Constructs that were used to measure qualitative 
data encompass “credibility, transferability, dependability, and conformability” 
(Rudestam & Newton, 2007, p. 112). This process should ensure the study can be 
considered believable and fulfills the requirements that data can be transferred for 
quality, trustworthiness, replication, and objectivity for a replicated study (Lincoln & 
Guba, 1985; Rudestam & Newton, 2007). 
Results from both strands were combined to connect both datasets; the qualitative 
approach builds upon the quantitative phase and was used to support the results of the 





of the research problem (Boeije et al., 2013; Creswell, 2006; Franz et al., 2013; Heyvaert 
et al., 2013). The goal is to produce robust results that might not be attained using only 
one method.  
Role of the Researcher 
Creswell (1998) said a researcher must be aware of the basic fundamentals of the 
selected method of inquiry and must have a clear understanding of the research processes. 
For this study, I used quantitative data from cancer databases of the ACR, ACS, CDC, 
and the NCI for a specific area of California between 2010 and 2012. For the qualitative 
inquiry, I designed the questionnaire, pilot tested it, administered it, and then collected 
and analyzed resulting data (Creswell, 1998; Simon & Goes, 2013). For a robust 
experiment and outcome, the researcher must disclose biases, suppositions, and 
perspectives (Creswell, 1998; Simon & Goes, 2013). To assure my objectivity, I put aside 
personal biases during the interviews, did not lead participants to respond in a particular 
way, and kept a journal for personal reflections (Simon & Goes, 2013).  
Methodology 
Selection of Participants for Quantitative Data 
Records of 10,000 women ages 24 to 74 were taken from the 2010-2012 
databases of the ACR, ACS, CDC, CDPH, and NCI to identify those who had a diagnosis 
of DBT. From that group, every 20
th
 name was selected to participate, yielding a potential 
N of 500 (Trochim, 2001). The confidence level was expected to be 95% with a margin 





samples of conventional mammography and MRI imaging methods (Simon & Goes, 
2013). A broad age selection follows what breast cancer foundations and registries report 
and should reflect accurate application to both older and younger women. Younger 
women inherently have DBT, and most postmenopausal women who are not using 
hormone replacement therapy also have DBT (Berg, 2009). The systematic random 
sample means each woman with a dense breast finding has the same chance of being 
selected (Creswell, 2007). Power analysis was used to calculate an adequate sample size 
for a statistical test (Rudestam & Newton, 2007). If a sample size is too small, the 
investigation will not have enough power to answer the research question adequately. If a 
sample is too large, it can create inaccuracies by highlighting insignificant variables, 
making the goodness-of-fit test too sensitive and leading to the determination that 500 
participants would be required (Rudestam & Newton, 2007; Simon & Goes, 2012). The 
quantitative survey (See Appendix B) consisted of 11 questions with a Likert rating scale 
of five choices. The survey is comprised of the following questions.  
1. Is your age between 24 and 74 years? 
2. Are you in good health? 
3. Do you have a family history of breast cancer? 
4. Have you lost a family member to breast cancer who had regular 
mammography screenings? 
5. Do you regularly perform a breast self-exam? 





7. Have you had screening mammograms every year for the last 5 years? 
8. Have you had an abnormal mammogram finding? 
9. Did your doctor tell you that the result of your mammogram was not 
conclusive? 
10. Is this the only available way you know of to screen for breast cancer? 
11. Do you know women who had normal mammograms during their years of 
screening and have had a subsequent breast cancer diagnosis? 
Qualitative Selection 
Participant selection for interviews followed the guidelines for purposeful 
sampling (Creswell, 2007). Because this investigation follows the guidelines of 
phenomenology theory, a sample size of 20 participants was selected from the database 
of the California Department of Public Health (CDPH), from 2010 to 2012 using a full-
service breast-imaging center in San Jose. California physicians are required to report 
dense breast findings, and as such, information for this region is accessible for research. 
General information for contacting participants is also available for research purposes. I 
secured permission to have access to the study population.  
Qualitative recruitment began with an introductory letter e-mailed to 20 potential 
participants. The letter explained the study, who I am, and my contact information. Those 
who agreed to participate were sent an informed consent form that included a stamped, 
self-addressed envelope for returning the signed form. The informed consent explained 





collected, and the duration of the interviews. It also explain that there is no compensation 
for participation, that participation is voluntary, and that no personal information will be 
shared in any subsequent presentation of the results of the study. It also encouraged 
participation by telling participants the results might help other women who have had 
experiences similar to theirs. An informed consent document is shown at Appendix D. 
The respondents and researcher arranged the time for the interviews via e-mail. The semi-
structured interview will follow a script (Appendix C) and consist of open-ended 
questions as follows:  
1. Are you in the age group 24 to 74 years?  
2. Do you perform routine breast self-exams?  
3. Do you have a family history of breast cancer?  
4. Do you have an annual mammogram?  
5. Do you have DBT based on a mammogram?  
6. Were you told by her doctor that you needed a repeat mammogram? 
7. Have you had an ultrasound as a breast cancer screening? What was the 
finding? 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal 
mammogram finding? 
9. Describe your emotions before your doctor diagnosed your breast cancer. 
10. Do you believe your breast cancer could have been detected earlier if MRI 





To eliminate bias, I sent a follow up e-mail  to nonrespondents and  added the 
numbers to the total number of participants.  
Quantitative Instrumentation 
Instrumentation followed the guidelines of the mixed methods explanatory 
research design, where quantitative data collection is followed by qualitative data. For the 
quantitative phase, the survey instrument collected data from women with DBT who had 
a mammogram between 2010 and 2012 from databases of the ACR, ACS, CDC, CDPH, 
and NCI. SurveyMonkey was used to send surveys and collect responses to record each 
answer (Simon & Goes, 2012). SurveyMonkey is a fee-for-service program that enables a 
researcher to design an instrument for a targeted group and direct responses to a secure 
online site for retrieval. SurveyMonkey was appropriate for the quantitative strand of this 
experiment because it generates closed-end questions and collects responses for large 
populations in a short time (Simon & Goes, 2012). SurveyMonkey was downloaded to 
SPSS for analysis. Quantitative design studies in the nursing discipline (Hardy, 2011), 
social media (Roe, 2013), and social research (Stein, 2011) that used SurveyMonkey for 
data collection and analysis demonstrated the validity and reliability of the instrument.  
Validity and Reliability of the Quantitative Instrument 
If an instrument executes what it is intended to evaluate, then it is considered 
valid (Creswell, 2007). The face and content validity for the survey instrument were be 
tested for strengths and weaknesses. Content validity was corroborated by the cover letter 





(2003) suggested that the sample size chosen for the experiment must represent the target 
population. As noted before, G*Power, a computer software tool, was used to calculate 
the sample size for the quantitative portion of the study.  
Reliability of the survey instrument was measured for its reproducibility, stability, 
and consistency (Creswell, 2007). Test and retest were also used to measure reliability. 
with the determination that if same assessment were given to the same group, and the 
same procedures were replicated, then the results should be consistent, making the tool 
reliable (Creswell, 2007). SPSS was used to test the reliability of the Likert-type scale 
questions using Cronbach’s alpha (Frankfort-Nachmias & Nachmias, 2007; Simon & 
Goes, 2013).  
Qualitative Instrument 
Qualitative data came from open-ended interviews (Patton, 2002, p. 4). Patton 
(2002) suggested that interviews provide responses that can lead to a better understanding 
of a research question. The interviews were guided by a short-answer questionnaire I 
conducted. The conversations with participants were recorded for later review. Creswell 
(2007) suggested that open-ended questions allow a researcher to control the questioning 
and prompt participants for more details (Creswell, 2007, p.179). I encouraged 
participants to speak freely about their experiences with the disease during the 30-minute 
interviews.  
The questions I used were guided by a focus on the following: 





2. What am I attempting to find out? 
3. Why is the information needed? 
4. Are the questions reasonable? 
5. How will the results help to identify additional breast cancer screening 
methods for women with DBT? 
Validity and Reliability of the Qualitative Instrument 
Credibility, conformability, consistency, and applicability are criteria used to test 
a qualitative instrument (Lincoln & Guba, 1985; Rudestam & Newton, 2007). The 
premise of qualitative research is to explain the phenomenon and to create a better 
understanding of the topic. Lincoln and Guba (1985) argued that an instrument must be 
believable. It must capture data in the correct setting, where correct procedures are 
followed for data collection, and the researcher must have participant consent for that 
data collection (1985). Credibility of the instrument can also lead to greater 
generalizability of the results (Johnson, 1997; Stenbacka, 2001).  
The third test an instrument must undergo is conformability: A plan must be 
evident in the research report, and member checking of the answers must be done to 
eliminate researcher bias (Lincoln & Guba, 1985). If the researcher is biased, the bias 
may influence the data collection procedure and subsequent analysis, and the study may 
not be fundamentally solid. The fourth criterion is consistency. Campbell (1996) 
suggested that the consistency of the instrument can be validated by the assessment of 





sets, repeating questions for consistency, and clarifying answers with participants for 
transparency.  
Procedures for the Pilot Study 
Before any contact was made with participants, I had permission from the IRB at 
Walden University, IRB Approval # 10-07-14-0078441, to pilot test the questions before 
they were asked of participants. The purpose of this was to find and correct errors in 
content or wording, based on responses from the pilot study group (De Kok et al., 2010). 
Results were discussed with an experienced principal investigator to ascertain if 
responses given by the participants fit the criteria of credibility, conformability, 
consistency, and applicability that Lincoln and Guba (1985) proposed.  
The purpose of a pilot study is to test the achievability of the full scale study, 
determine the possibility of its success, and highlight barriers that may affect the progress 
and completion of the study (De Kok et al., 2010; Given, 2008). The pilot study 
questionnaire consisted of the following questions: 
1. What age group are you?  
2. What prompted you to get breast imaging? 
3. Were you told that you have DBT? 
4. What was your breast density measurement? 
5. What kind of breast imaging did you have? Ultrasound or MRI?  
6. Which one was first?  





8. How long did you wait before you were given a diagnosis? 
9. Did you receive treatment?  
10. What is your prognosis? 
Based on responses to the pilot study, I determined the questions elicited the 
information I was seeking (De Kok et al., 2010). I then evaluated the answers and 
changed questions as necessary (Lincoln & Guba, 1985). To further authenticate the 
study, I requested a panel of three experts in the field of breast imaging and breast cancer 
research to provide expertise in their breast cancer imaging methods and imaging 
methods for DBT.  
Panel of Experts 
The expert panel for the pilot study was comprised of one breast cancer clinical 
physician, one radiologist who interprets breast cancer imaging examinations, and one 
PhD breast cancer researcher, as they know disease diagnosis, interpretation of imaging 
for breast cancer, and the research about the disease. I sent an introductory e-mail to each 
to achieve  
1. An introduction to the researcher 
2. The purpose of the pilot study. 
3. An explanation of how their participation will help the study. 
4. Determination of their interest in participating 
Based on their responses, I called to confirm their interest and told them the 





with them by e-mail, and that I would amend the qquestionnaire as needed based on their 
responses. The questionnaire for the expert panel is included at Appendix F.  
Data Analysis Plan 
Quantitative  
The null and alternative hypotheses below were considered in the data analysis 
plan.  
H0: MRI technique for screening women with DBT should be used as an adjunct 
to conventional mammography.  
H1: MRI technique for screening women with DBT should not be used as an 
adjunct to conventional mammography. 
Statistical Package for the Social Sciences (SPSS) was used for the data analysis 
for the quantitative strand. Data collected from the surveys reflected both respondents 
and nonrespondents will be added to the computation to eliminate bias, as referenced by 
Creswell (2009). Creswell suggested that the inclusion of nonrespondents could 
potentially address and eliminate bias in the study and could show whether the research 
findings might change the study.  
The initial step in the data analysis process followed processes described by 
Trochim (2001), Creswell (2009), and Simon and Goes (2013). Data analysis followed 
the steps of data entry, data organization, data screening, and data cleaning. After I 
collected data, I organized and prepared it in a logical form using an Excel spreadsheet 





collected (Trochim, 2001). I further evaluated the information by a visual check of the 
printed data and used a text editor to check for inaccuracies and errors (Jarausch & 
Hardy, 1991, p. 53). Additionally, I cleaned data by checking for duplicate records, 
missing data sets, and inconsistencies. Any errors were corrected and reentered into SSPS 
(Jarausch & Hardy, 1991).  
Data screening was used to check for data accuracy by use of histograms and 
charts. I also performed a visual check for admissible and impossible values in the 
datasets, a process that helped to locate and edit incorrect data (Jarausch & Hardy, 1991, 
pp. 40-41; Simon & Goes, 2012, p. 185). Interval data was the level of measurement 
because these kinds of data have an order that follows the Likert scale (Creswell, 2009; 
Simon & Goes, 2013). The sequence of quantitative data analysis for the study followed 
with the selection of the statistical test.  
The two-tailed t test was then used to test the hypothesis that MRI or ultrasound 
should be used to screen for breast cancer in the dense breast population (Field, 2009). A 
two-tailed test was used because the hypothesis is nondirectional, meaning that the claim 
neither supports nor rejects the hypothesis (Field, 2009). Hypothesis testing was done 
with the use of the probability or p value method, a statistical test to show the power of 
what is being tested (Simon & Goes, 2013). If the p value has a value that is less than 
0.01, there is a possibility that the null hypothesis will be rejected (Simon & Goes, 2013). 
Hypothesis testing for this study was done to accept or reject the null hypothesis (Field, 






The initial step in data analysis is data review. For this process, I applied data 
reduction, where large amounts of data collected from the interviews were organized and 
prepared for analysis (Creswell, 2009). I then reviewed and examined the information to 
understand meanings and reveal concepts about what participants said about their 
experiences. I also followed the inductive process of axial coding. Creswell (2009), 
Trochin (2001), and Rudestam and Newton (2007) recommend axial coding as part of 
data analysis because the process can find commonalities. In addition, I used preset codes 
to find common words and phrases and looked for emergent codes that arose from the 
data. Axial coding, preset codes, and emergent codes identified specific words and 
phrases from the interviews. Although Creswell (2009) recommends that the emergent 
code method is commonly used for social science studies, preset codes for this mixed 
methods investigation illuminated the importance of the topic. At this juncture, Creswell 
(2009) also recommended that the researcher should review the coded data again for a 
holistic view of the research phenomenon, recheck the raw data collected from the 
interviews, and recheck codes assigned to data already reviewed, an additional step that 
aids a qualitative researcher to check for missed codes and perhaps add new codes to the 
data. The data were then checked for similarities, differences, patterns, and relationships 
by an Excel matrix to provide a holistic view of the phenomena (Miles & Huberman, 
1994). Coded data were downloaded to NVivo for final analysis (Creswell, 2009). At this 





did not help to support the research question, and drew implications from the findings to 
be represented in a narrative format (Krathwohl, 1988; Miles & Huberman, 1994). 
Creswell (2009) recommended that a researcher can present the findings of a qualitative 
study in narrative format and add tables, figures, and visuals as adjuncts to illustrate the 
findings.  
Mixing the Qualitative and Qualitative Approaches 
Integration of the quantitative and qualitative strands in social research is 
daunting, according to Creswell (2009). Among several mixed methods supporters, 
Creswell (2009), Creswell and Plano Clark (2007), and Mackay (2004) suggested that 
matrices such as timing, weighing, mixing, and theorizing (Creswell, 2009, p. 207) are 
essential criteria researchers can follow in a mixed methods approach. The sequential 
explanatory approach was used for this study because the quantitative approach alone 
was not adequate to answer the research question. Therefore, I also employed the 
qualitative to illuminate the findings of the quantitative findings. In addition, I used 
triangulation to strengthen the sequential explanatory approach of the investigation.  
Threats to Validity 
Validity is a measure that accurately represents the true premise and the 
soundness of the study (Hammersley, 1988). For a study to be valid, the researcher 
follows the appropriate steps to achieve validity. However, there are threats that can 
affect that validity (Creswell, 2009). The researcher must identify these threats and offer 





is a determination of how the precision of information and conclusions drawn from a 
study can be generalized to the population. If the study does not meet these criteria, then 
the study may be invalid (Seliger & Shohamy, 1989). Internal validity measures the 
accuracy of the data collected and conclusions gathered that represent the phenomena 
being studied. Internal validity also tests parameters within the design of the study itself 
for inconsistencies (Seliger & Shohamy, 1989).  
External Validity 
Trochim (2001) suggested that external validity is a measure of how accurate the 
data and the conclusion of the study are and whether they are generalizable to the 
population being studied. One threat to external validity can be small sample size (p. 42). 
For the quantitative strand of this study, I used random sampling so that each potential 
participant had the same chance of being selected (Creswell, 2009; Trochim 2001). A 
second threat to external validity could be lack of replicability or transferability. The 
researcher must be aware of the clarity and simplification of steps and must note them 
clearly for replicability (Creswell, 2009). The data collection instrument must do as it 
purports to do, or there may be an external threat to the validity of the study (Creswell, 
2009). External validity in qualitative research is the transferability of the findings to 
analogous groups (Lincoln & Guba, 1986).  
Construct Validity 
A major threat to external validity could be construct validity, an assessment of 





measure (Trochim, 2001). For this study, I used SurveyMonkey to collect quantitative 
data, semi-structured open-ended questions to collect qualitative data, and a panel of 
experts on the phenomenon being studied to triangulate the data. Wainer and Braun 
(1988) stated that there must be a detailed step-by-step process for a study. If the 
procedures are disorganized, a study can lose its credibility. Although Creswell and 
Miller (2000) suggested that external validity does not affect qualitative research, the 
researcher must be mindful of the sample size for the qualitative strand of the study. Data 
must be collected until there is a saturation point and a model arises. This maneuver will 
add to the credibility of the study and can show whether the researcher was scrupulous in 
data collection and analysis.  
Internal Validity 
Threats to internal validity include lack of credibility, transferability, 
dependability, or conformability. (Denzin & Lincoln, 1998; Guba & Lincoln, 1989; 
Hammersley, 1987; Mishler, 1990; Wolcott, 1990). I conducted external audit checks and 
triangulation to minimize threats to the study (Simon & Goes, 2013, p. 81).  I also tested 
questionnaires for reliability by member checking (Simon & Goes, 2013, p. 81). I also 
used semi-structured, open-ended questions to collected data from participants; this tool 
was reviewed by experts for construct and face validity (Creswell, 2009) and whether 






I added to the credibility of the study by collecting rich data from participants 
who have lived with DBT, have been screened by traditional mammography, and may or 
may not have been screened by an alternate method. Trustworthiness was measured by 
transferability, in that the procedure could be shifted to another circumstance. I kept 
detailed records during the study and followed stringent guidelines for data collection and 
analysis processes.  
Accuracy of transcriptions was determined by member checking to assure that I 
recorded my questions and participants’ responses accurately. I sent transcripts of the 
interviews for participant review and corrected or changed their responses at their 
request. NVivo codes generated from themes in the data were recorded and applied 
consistently.  
Ethical Procedures 
Researchers must follow ethical guidelines for the entirety of the research process. 
I followed the guidelines of the Walden University IRB and collected data after I 
received approval to conduct the study. There was no physical harm or risk to 
participants in this study, and each gave signed consent and acknowledged that their 
participation was entirely voluntary. Participants were told they could withdraw from the 
study at any time. I identified participants by number only, and no personal information is 
linked to the study. All personal data was considered confidential and secured in a 





password-protected computer that only I have access to. After 5 years, all data will be 
destroyed. 
Summary 
This chapter presented the methods used to determine from women with DBT 
what their experience has been with traditional mammography. The purpose of the study 
was to determine whether the health of women with DBT who are not part of the high-
risk population is endangered because there is no alternative screening method used as an 
adjunct to traditional mammography. 






Chapter 4: Results  
Introduction  
The purpose of this mixed methods study was to investigate to what extent 
mammograms can miss cancer in women with DBT and to find out if an adjunct method 
of imaging DBT might detect breast cancers that are missed by mammography alone. 
This chapter was organized to incorporate the research questions to determine which 
diagnostic technique other than conventional mammography was most effective to detect 
cancer in DBT. The two research questions were as follows: 
Research Question 1: Should MRI be used for screening women with DBT as an 
adjunct to conventional mammography? 
Research Question 2: What are the lived experiences of women with breast cancer 
in DBT prior to and after the breast cancer diagnosis?  
A randomized survey research design was used to administer and collect 
quantitative data. A two-tailed t test was used to test H0 using an Excel spreadsheet to 
organize, manage, and track data. The Statistical Package for the Social Sciences (SPSS), 
version 21, was used to analyze data collected. The second phase of the study utilized the 
phenomenological approach. The purpose of this qualitative strand was to learn, collect, 
and analyze lived experiences from participants between the ages of 24 and 74 years 
about dense breast imaging and explore which diagnostic imaging techniques were used 





This chapter includes the setting of the study, a brief discussion of the expert 
panel, why the expert panel was used, participant demographics, data collection, and data 
analysis. As noted in Chapter 3, the mixed methods explanatory design was employed 
where data collection and analysis for the quantitative strand of the study was conducted 
in the first phase (Campbell & Fiske, 1959; Jick, 1959; Creswell, 2009, & Plano Clark, 
2007). The results of the study conclude the chapter.  
Expert Panel 
Experts on breast cancer research and diagnosis were used in this study to check 
content validity of the research questions that I used for this study, to determine the 
possibility of its success and to highlight any barriers that might affect its success (De 
Kok et al., 2010; Given, 2008). All experts responded that the content of proposed 
questions was appropriate, that the content of questions was simple enough for 
participants and did not pose ambiguity. Based on this response from the expert panel, 
there was no change in the wording of the proposed questions for the quantitative survey 
and qualitative interview questions. 
Setting 
Surveys–Quantitative 
I e-mailed surveys to a random sample of potential participants who had one week 
to complete and return them. The survey contained 11 closed ended questions (Appendix 






A recruitment poster (shown in Appendix C) was placed at a breast care center for 
1 week, with information about the study and my contact information to respond to if 
there was interest in participating. At day four, I had received 10 responses. I contacted 
each of them to explain the study, sent them follow-up e-mails, received consent to 
participate in the study, and definite times were arranged to conduct the telephone 
interview. 
There were no personal or organizational conditions I know of that might have 
influenced participants at the time of the study that may have affected my interpretation 
of the study results. Neither those in the quantitative and qualitative parts of the study 
were influenced or coerced to participate in the study as stated in the Consent Forms A 
and B that were provided for them (shown in Appendix D and E). Each participant 
understood that they had the option to withdraw from study participation at any time.  
Participant Demographics 
A sample size of 300 women participated in the quantitative part of the study and 
10 respondents participated in the qualitative strand. A power analysis tool, G*Power was 
used to calculate the appropriate sample of 300 participants for the quantitative part of the 
study (Faul, Erdfelder, Lang, & Buchner, 2007). A sample size of 10 is judged sufficient 
for phenomenological investigations (Rudestam & Newton, 2007).  
Participants for the quantitative portion were randomly selected from women who 





between 2010 -2012, were between 24 and 74  years of age, had no history of breast 
cancer, and had a dense breast tissue finding. These criteria are outlined in Consent Form 
A.  
Participants for the qualitative part of the study were purposely selected from the 
breast care center of Regional Medical Center of San Jose. They were residents of Santa 
Clara County in California, had a screening mammogram between 2010 and 2012, were 
between 24 and 74 years of age, had no history of breast cancer, and had a dense breast 
tissue finding. These criteria are outlined in Consent Form B.  
Data Collection 
Quantitative 
Three hundred participants for the quantitative were randomly selected from 
Santa Clara County in California, and data were collected via SurveyMonkey, an online 
data-collection service. All participants who agreed to participate in the study had the 
option to stop the process after reviewing the consent form shown in Appendix D. The 
survey contained 11 closed-end questions: 
1. Is your age between 24 and 74 years? 
2. Are you in good health? 
3. Do you have a family history of breast cancer? 
4. Have you lost a family member to breast cancer who had regular 
mammography screenings? 





6. Do you have a screening mammogram every year? 
7. Have you had screening mammograms every year for the last 5 years? 
8. Have you had an abnormal mammogram finding? 
9. Did your doctor tell you that the result of your mammogram was not 
conclusive? 
10. Do you think a screening mammogram is the only available way to screen 
women for breast cancer? Did you have an ultrasound ? 
Each question had a choice of 5 responses that were based on a 5-point Likert 
scale, as shown in Appendix F. The five response choices were: strongly agree, agree, 
neither agree nor disagree, disagree, or strongly disagree. E-mail invitations were sent 
between October 10-15, 2014. When respondent’s participation reached the saturation 
point of 300 completed surveys, the participant field was closed. The online survey site 
was accessible by user identification and a unique password, and I had sole access to the 
completed surveys. I accessed the SurveyMonkey website and extracted the data. The 
aim of the survey was to specifically to capture women that fit the required criteria and 
the survey was formatted in such a way that prevented the participant to continue if the 
specified criteria were not met. These inclusion criteria are shown in Consent Form A.  
Qualitative  
Advertisement flyers were placed at the Regional Medical Center breast care 
center in Santa Clara County from November 3, 2014 to November 7, 2014 to recruit 





provide breast care services to a large community of women in Santa Clara County. 
Those who wanted to participate in the study responded to me by e-mail. I responded 
with Consent Form B (Appendix E), which specified they could withdraw from the study 
at any time for any reason. 
Data collection for the qualitative part of the study was conducted by telephone 
from the first 10 respondents. The survey contained 5 open-ended questions as shown in 
Appendix F: 
1. Are you in the age group of 24 and 74 years? Do you perform routine 
breast self-exams? Do you have a family history of breast cancer? Do you 
have an annual mammogram? Do you have dense breast tissue based on a 
mammogram? Were you told by her doctor that you needed a repeat 
mammogram? 
2. Have you had an ultrasound as a breast cancer screening? What was the 
finding? 
3. Did an MRI confirm your breast cancer diagnosis after the abnormal 
mammogram finding? 
4. Explain how you felt emotionally during the time it took for your doctor to 
make a diagnosis for your breast cancer? 
5. Do you believe that your breast cancer could have been detected earlier if 






Participants were allowed a maximum of 5 minutes to respond to each question; 
they were advised to set aside 30 minutes of uninterrupted time to complete the 
interview. At the agreed time, I contacted each participant by telephone;all responses 
were recorded by manual transcription. In addition, all interviewees were informed that 
they might be asked to review the transcribed interview for accuracy.  
There were no unusual circumstances to report for the quantitative and qualitative 
data collection processes.  
Data Analysis 
The study employed a mixed methods explanatory approach (Creswell & Plano 
Clark, 2008) and a qualitative approach. Table 1 below shows the tool used to collect 
data, the scale used classify data collected and data analysis tool that were used for this 
study. 
Table 1 
Data Analysis Tools  
Data collection   Measurement scale  Data analysis tools 
Survey  String/numeric  SPSS version 21 
Telephone interviews  String  NVivo 10 
 
Quantitative Data Analysis Using SPSS 
Responses that were received from 300 respondents, based on a 5 point Likert 
scale, were assigned a numeric code to match the actual participant response: 1= strongly 
agree ; 2= agree;3 = neither agree nor disagree; 4=disagree ; and 5 = strongly disagree. 





program Statistical Package for the Social Sciences (SPSS) version 21. A total of 3,000 
Likert scale responses were imported from an Excel sspreadsheet into the data view 
within the data editor of SPSS Version 2. Variables on the variable view of the data 
editor were labeled age, good health, family history of breast cancer, lost a family 
member to breast cancer, regular breast self-exams, annual screening mammogram, 
screening mammograms for the last five years, abnormal mammogram finding, and result 
of your mammogram abnormal. Importantly, on the variable view, each variable was 
assigned a type. This selection allowed for all string values to convert to numeric values 
in the data view of the data editor. The value label toggle selection in the data view 
allowed switching between string and numeric data in the date editor in the SPSS 
processor to allow numeric analysis of the total responses to each question. Two levels of 
data analysis were calculated: descriptive statistics and the t test. 
A descriptive statistical analysis of responses from N = 300 was done for all 
queries to look at the distribution. SPSS produced an output statistical table that showed 
descriptive statistics for the minimum and maximum of the scale, mean and standard 
deviation of N = 300. The descriptive statistics table is shown in Appendix H. The sample 
mean was not adequate to reject H0. Hence, the stem and lleaf plot analysis was done. 
This analysis considered the entire sample, analyzed to display all variables, data value, 
and their connection to other values such as confidence interval for mean, median, 
variance standard deviation, and skewness. The stem and leaf analysis also revealed 





H0 that would stop the significance test. The stem and leaf analysis table is shown in 
Appendix H. 
The t test was the final computation for N = 300. The one-sample two-tailed t test 
was employed to test the hypothesis for the research. The two-tailed t test was selected 
because it can detect deviation on either side of H0. In the data view display within the 
data editor of SPSS, the one sample t test was selected. All variables were analyzed with 
a test value of 1. The test value 1 is not an arbitrary number and was selected because the 
H0 =1. A one-sample sstatistics table and the one-sample test table were generated.  
The one-sample sstatistics table, shown in Appendix J, displayed each variable 
that tested  N = 300: mmean, sstandard ddeviation and the sstandard eerror  mean. The 
importance of the one-sample sstatistics table is that it shows whether the correct sample 
was analyzed. The one-sample test table provided the t statistic, df (degrees of freedom), 
the significance (2-tailed) output, mean difference, and the confidence interval. Each 
variable was analyzed to determine if H0 was rejected by this analysis.  
The t statistic for each of the 10 items analyzed yielded values that range from 6.3 
-104. Under H0, the t statistic = 0. This distribution placed the values for the t statistic 
won the right tail of the distribution which means that H0 can be rejected.  
The df, N-1 =  299, is standard for a one-sample t test. This is an important 
variable in the analysis because df tells the software which t distribution to look at to 





The significance reported a p value of 0.00. The two-tailed test was selected to 
detect variations on either side of H0, as if there are deviations above or below the mean, 
H0 can be rejected, hence the purpose of a two-tailed test. As suggested in Chapter 3, if 
the p value has a value < 0.01, there is a possibility that the null hypothesis will be 
rejected (Simon & Goes, 2013). The p value in this analysis wass < 0.01. Therefore, H0 
was rejected. The research question as proposed by H0 in Chapter 3 that MRI for 
screening women with DBT should be used as an adjunct to conventional mammography 
was rejected.  
The md of the analysis reported values from 0.173–3.4. This represents the 
difference between the population and sample mean, as shown in Appendix I. If  H0 was 
true, md = 0. However md is not equal to zero, and  H0 can be rejected.  
The analysis reported a 95% cconfidence interval, (CI) with llower and uupper 
bounds. The CI can be used to test H0. If the md =0, under H0 , 0 will not fall between the 
llower and uupper bounds of CI, but will fall outside of the CI. This is evidence to reject 
H0 at the .05 level of the CI. With a CI of 95%, the llower and upper bounds will capture 
the true population mean, and in 5%, it will not.  
As noted in Chapter 3, if the p value is < 0.01, will be rejected, H1 will be upheld 
(Simon & Goes, 2013), and the investigation can continue to the second phase.  
Qualitative Data Analysis Using NVivo 
I transcribed telephone interviews with 10 participants and saved the data as a 





Ten word documents were created and named to match each participant and responses. 
To ensure accuracy of the responses, I e-mailed the transcribed responses to each 
participant and asked them to read their responses and check for accuracy.  
Data were organized by numbers in NVivo 10 in the ssource workspace. 
Questions and responses from each interview that were saved previously to a Word 
document were imported and matched to the respective participant in the NVivo 10 
workspace. When each participant was selected, the question and their responses were 
displayed. As I examined responses to the five questions I asked each participant, 11 
themes emerged. Each theme was created and entered into the node workspace of the 
NVivo 10 program.   
Question 1  
Qualitative Research Question 2: “What are the lived experiences of women with 
breast cancer in DBT prior to and after a breast cancer diagnosis?” To answer this 
question participants were asked to respond to five questions (shown in Appendix F). The 
first question had six sub-questions. Six themes emerged from their answers. Each theme 
is discussed below. 
Theme 1. Are you in the age group 25 through 75 years? Participants’ ages 
ranged from 30 to 68. This age group is important for this investigation because younger 






Theme 2. Do you perform routine breast self-exam? All participants responded 
that they performed breast self-exam. Participant 1 responded that she found a lump in 
her left breast during a self-exam. She was 68 years old, had had normal screening 
mammograms since she was age 40, but in her 50s, there was a dense breast finding. She 
had additional diagnostic imaging with a repeat mammogram and an ultrasound, but 
these exams did not yield more information about her abnormal mammogram finding. 
This is key to the study because their breast anomalies were missed with mammogram. 
Even though Participant 1 followed all the rules and had annual screening for 10 years, 
cancer had not been detected. The lump in her left breast was found when she did a breast 
self-exams.  
Theme 3. Do you have a family history of breast cancer? All participants 
responded that there was no history of breast cancer. This was a criterion to participate in 
the study as proposed in Chapter 1. The study examined the purposeful sample that did 
not have a breast cancer history.  
Theme 4. Do you have an annual mammogram? All participants responded 
positively to this question. This response met the inclusion criteria for the study also. The 
aim of this question is to find out if the outcome would be the same if these participants 
did not have a screening mammogram.  
Theme 5. Do you have dense breast tissue based on a mammogram? All 





which diagnostic imaging technique was used to image this group and if the finding was 
cancerous.  
Theme 6. Were you told by your doctor that you needed a repeat mammogram? 
Participants 1, 2, 3, 4, 9 and 10 had repeat mammograms and reported that the repeat 
mammograms did not provide new information and that their doctors were not able to 
provide clarity. Their doctors recommended an additional diagnostic test. 
Question 2  
Theme 7.  Have you had an ultrasound as a breast cancer screening? Two 
themes emerged from question2.  Eighty percent of participants reported that an 
uultrasound exam was recommended after the second mammogram because the results of 
the screening and repeat mammograms were not conclusive. Participant 5 said her doctor 
was very conservative, but she agreed to go through with more testing, as she was only 
55 years old and was the breadwinner in her family.  
Theme 8. What was the finding? Participants reported being relieved that their 
physicians were not ignoring them and ordered more diagnostic tests to help make the 
diagnosis. Participants 1, 2, and 4, said the ultrasound results were not conclusive; 
Participants 3, 5, 6, and 7, said their ultrasound results said the area was too small, and 
Participants  8, 9, and 10 stated that the ultrasound did not give more information. I 
observed that these participants were well informed about dense breast findings and were 






Theme 9. Did an MRI confirm your breast cancer diagnosis after the abnormal 
mammogram finding? All participants expressed their dislike for the MRI scan. They 
reported that test took about 45 minutes to one hour to complete but that it provided more 
information that mammograms and ultrasound exams. The majority of participants said 
that the results of the MRI reported breast cancer or suggested breast cancer. 
Question 4 
Theme 10.  Explain how you felt emotionally during the time it took for your 
doctor to make a diagnosis for your breast cancer? The purpose of this question was to 
find out the emotional state of the women while they waited to schedule appointments for 
additional tests so that physicians could make a diagnosis. The common concern for all 
was the length of time they had to wait while they had repeated mammograms and 
ultrasound exams. They were concerned that the cancer was not diagnosed early enough 
or misdiagnosed and that they might not have enough time for treatment and recovery. 
Some were concerned that they could possibility need a mastectomy. One of the common 
concerns that all participants had was that there was too much time wasted on the repeat 
mammogram and ultrasound exams.  
Question 5  
Theme 11. Do you believe that your breast cancer could have been detected 





This question was included so I could learn whether participants were informed about 
breast cancer in dense breast tissue and diagnostic imaging techniques that are available 
for breast cancer screening. Most agreed that mammograms can miss anomalies in dense 
breast tissue and that they were not pleased to repeat the mammogram because of 
radiation. Additionally, more that 80 % of respondents said that the ultrasound did not 
give additional information because the technique is not useful for dense breasts. 
Although the MRI exam was very uncomfortable and look a long time, the majority of 
participants said that it was the most accurate test that confirmed breast cancer. Major 
themes are shown in Appendix K.  
Evidence of Trustworthiness 
This study fulfilled the construct validity by using the opinions from an expert 
panel: a radiologist, a research scientist, and a physician. Each member sent feedback that 
validated the content of the quantitative and qualitative survey tool. Member checking 
was used to confirm the accuracy of my transcriptions. Each transcribed telephone 
interview was sent to participants to review their answers to the interview questions. The 
study could be replicated in another case by following my detailed records.  
Summary 
To learn the lived experiences of women with dense breast tissue and breast 
cancer who had undergone tests for breast cancer, I conducted a qualitative study by 
interviewing 10 women. Answers to five open-ended questions and responses from 





addition to conventional mammography, is needed to screen women with dense breast 
tissue. 
Chapter 5 will present an interpretation of the study, including limiting factors, 
recommendations for future research, and how the results of the study might effect 






Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
Breast cancer in DBT can go undetected with conventional screening methods 
(Are You Dense? 2013), yet there are no directives in place for agencies and 
organizations to screen women with DBT  (ACR, 2013; ACS, 2012; CDC, 2013). 
Women with DBT who are not predisposed to breast cancer and do not have a breast 
cancer history are in the low-risk category and do not meet the standard for additional 
breast cancer screening. Conventional breast screening is the only screening technique 
that is used for this group; but using that technique alone can miss cancer in glandular 
tissues. Although conventional mammography is effective for regular breast cancer 
screening, this technique detects less than half of breast cancers in the population with 
DBT (Are You Dense? 2013). A mixed-methods, sequential, explanatory approach was 
used for this study because health studies are very complex, and it was believed that 
adopting this approach could maximize the strengths of quantitative and qualitative data 
collectively. The use of a single approach, quantitative or qualitative, would not have 
been sufficient to answer the research questions.  
This study was guided by two research questions: (a) Should MRI be used for 
screening women with DBT as an adjunct to conventional mammography? and (b) What 
are the lived experiences of women with breast cancer in DBT prior to and after the 





and interpret the findings, discuss limitations, and present the recommendations and 
implications of the findings. 
Purpose and Nature of the Study; Key Findings 
The purpose of this mixed methods study was to explore, investigate and examine 
to what extent mammograms and ultrasound techniques can miss cancer in women with 
DBT. Consequently, I wanted to find out if the application of MRI techniques in the DBT 
group might detect breast cancers that were undetected by mammogram and ultrasound. I 
also wanted to learn about the journey that women with DBT experienced when they 
found out that they had an abnormal finding and the process that they went through to get 
the breast cancer diagnosis. 
The first strand, the quantitative part of the study, was done to find out how many 
abnormal findings there were in a random sample of 300 women. The second strand, the 
qualitative part, was done to learn about lived experiences of women with DBT and the 
journey they travelled to get to the cancer diagnosis. The purpose of the study was to add 
information deduced from this study to existing literature about the need to add an 
adjunct imaging technique to conventional screening methods to effectively screen 
women with DBT. The proposed adjunct screening is the use of MRI techniques.  
In a conventional screening of a random, healthy sample of 300 women N = 300, 
with a DBT variable, 93% reported that they had abnormal breast findings. This analysis 
was provided by the application of a mathematical computation called SPSS (Table 2). 





such a significant population with abnormal breast findings and since mammograms and 
ultrasound techniques can miss cancers with DBT (see the literature review for an 
exhaustive review), then there is a need for a technique that has a higher sensitivity to 
DBT. 
Table 2 
Abnormal Mammogram Findings 1 
Scale Frequency Percent Valid percent Cumulative percent 
Valid 
1 40 13.3 13.3 13.3 
2 240 80.0 80.0 93.3 
3 3 1.0 1.0 94.3 
4 12 4.0 4.0 98.3 
5 5 1.7 1.7 100.0 
Total 300 100.0 100.0  
 
Note: 93% of N=300 had an abnormal breast finding. 
Findings from the qualitative portion revealed that women with DBT that do not 
have a breast cancer history may undergo arduous breast screening processes before an 
actual diagnosis. Repeat screening mammograms, diagnostic mammograms, and 
ultrasound are additional tests this group has to undergo. The results were that some 
women had screening reports with vague terminologies, findings that were inconclusive 
or unclear and the message that additional test are needed. Data analysis using NVivo 






Interpretation of the Findings 
This study was based on two inquiries: Which breast imaging technique can 
detect cancers in DBT and can be an adjunct to conventional mammography to screen for 
breast cancer? Which imaging technique was utilized by a purposeful group of women 
with DBT to get a breast cancer diagnosis? As discussed in Chapter 2, the ACR (2012) 
reported that 80% of women have dense breast tissue, and Berg (2009) reported that 
conventional mammography which is the standard to screen for breast cancer can miss 
cancers that are in these tissues. This study revealed that more than 90% of N = 300 had 
an abnormal mammogram finding. Table 3 shown below shows that from a random 
sample of 300 participants, 280 women had an abnormal mammogram result.  
Table 3  
Abnormal Mammogram Findings 2 
 Frequency Percent Valid Percent Cumulative Percent 
Valid 
1 40 13.3 13.3 13.3 
2 240 80.0 80.0 93.3 
3 3 1.0 1.0 94.3 
4 12 4.0 4.0 98.3 
5 5 1.7 1.7 100.0 
Total 300 100.0 100.0 
 
This finding confirmed that a significant population of women has DBT and an 
abnormal mammogram. In addition, these findings suggest that there is a need for an 
adjunct screening method for women with DBT because conventional mammogram can 





that DBT is not a significant finding for women that are in the asymptomatic category, 
but data collected for this study revealed that women with DBT that had MRI, that 
confirmed breast cancer.   
Qualitative data revealed that a significant number women that participated in the 
study in the age group 24–74, with dense breast tissue, without family history of cancer, 
and had annual screening mammograms, had breast cancer that was undetected. These 
women had breast screening with conventional mammogram and ultrasound. More than 
50% of these women had repeat mammograms, diagnostic mammograms, and ultrasound 
exams. Results from these exams were “non-conclusive,” “not clear,” or “more tests were 
needed.” All women had an MRI report of positive results. MRI has a high specificity to 
detect anomalies and cancers in granular tissues (Frank, 2011).  
Limitations of the Study 
One limitation is that e-mail surveys came only from residents of Santa Clara 
County, limiting the population to a small geographic area that may not be typical of 
women in general. Although statistics indicate that people are highly inclined to respond 
honestly to a survey like this, there is no way to determine if the questions asked were 
answered truthfully.  
Ultrasound can also produce false positive results (Berg, 2008) due to the lack of 
proficiency of operators and lack of standardized protocols. Berg (2008) also suggested 
that the quality of an ultrasound depends on the skill of the operator. All participants had 





the technologist or know what protocols were used. MRI can also produce false positive 
results. Descriptive statistics collected from the 20% of the women who participated in 
the qualitative part of the study showed they had breast biopsies to confirm breast cancer. 
The reason for a biopsy was unclear.  
After I had 10 positive responses, I stopped recruiting participants. These were all 
patients of one breast cancer center. There was no way to tell if the sample was slightly 
larger than 10 and what descriptive data might yield from a larger sample. It is also not 
clear if these results can be applied to the general population.  
The weight of the methodology possibly weighed slightly heavily towards the 
quantitative than qualitative data. 
The final limitation for the study could be the right point in data collection to mix 
results of collection, analysis, or interpretation (Creswell, 2009). Quantitative data were 
analyzed first.  
Recommendations 
The findings of this study prompted several recommendations. That health 
organizations and agencies set a standard that MRI screening should be used with 
conventional mammograms to screen women with DBT for breast cancer because of its 
high sensitivity to DBT (Berg, 2009; Frank, 2011). Health care providers, however, 
should be aware of the significant number of women that are diagnosed with  DBT 
(ACR, 2012), and are positive for breast cancer, even though they do not have a family 





organizations should add this technique to conventional mammogram to screen for breast 
cancer. 
The mixed methods sequential explanatory approach was the most appropriate for 
this type of health investigation as it strengthened the robustness of the quantitative and 
qualitative strands (Creswell, 2009). The quantitative paradigm guided data collection 
and analysis, while the qualitative design guided the in-depth interviews and data 
analysis. Quantitative data were used to test H0 and explore the determination that more 
thorough and complete data are needed to determine without question that an adjunct 
imaging method is needed to screen women with dense breast tissue. 
Further research is needed to screen various groups of women with DBT, to 
compare the combination of  the effectiveness or not of mammograms and  ultrasound 
versus mammograms and MRI techniques. In addition, there was a low participation 
response for the women 25–50 for this study; therefore, the outcome for this group could 
not be measured.  
Implications 
Breast cancer, with a high mortality in the United States, is the second-most 
deadly disease in women (NCI, 2012). But if it is detected in an early stage, it can be 
treated effectively, and a positive prognosis is more likely. If MRI is used as an adjunct to 
conventional mammograms, accurate breast cancer results may be produced, a condition 
that might lead to a rapid breast cancer diagnosis, potentially lowering mortality rates for 





death. This is not to diminish the importance of breast self-examination and annual 
mammography screening processes that continue to be highly recommended. 
Conclusion 
Early detection of breast cancer can result in earlier treatment and decreased 
mortality rates for women with DBT. Imaging of DBT utilizing MRI has yielded accurate 
findings for breast cancer among the group of women with DBT and a lower number of 
false positive cases. MRI has a higher sensitivity for imaging DBT because it has unique 
characteristics to see inside dense tissues. If MRI is added to conventional 
mammography, there should be a higher diagnosis rate for breast cancer, and the disease 
can be treated in the early stages. Utilizing MRI to image women with DBT would bring 
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Appendix A: Cover Letter to Expert Panelists 
Dear Potential Participant,  
I am a doctoral student in the Walden University Health Services program. The 
university has approved my request to conduct research by granting me IRB approval 
number 10-07-14-0078441 to conduct this study. The reason for the survey is to fulfill 
the university’s requirement for the PhD and to request your expert opinion on the 
following question: Can or should MRI techniques be used with conventional 
mammograms to screen women with dense breast tissue for breast cancer?  
If you would like to participate in the study, please complete the enclosed six- 
question survey. The anticipated time to complete this survey is no longer than 15 
minutes, and the results will be used to support a larger study. After you complete the 
survey, please used the stamped, self-addressed envelope and mail your response within 7 
days. Your identity and responses will be kept confidential. If you are interested in 
participating, please send an e-mail to rachel.connett@waldenu.edu.  







Appendix B: Cover Letter to Participants for Quantitative Data Collection 
Dear Participant,  
I am a Ph.D. graduate student with Walden University, Health Services program 
and I am covered by IRB Approval # 10-07-14-0078441 to conduct this study. This 
purpose of this study is to determine if MRI techniques can be used along with 
conventional mammograms to screen women with dense breast tissue for breast cancer 
detection. The primary reason of the study is to fulfill the university’s requirement for the 
student to gain her Ph.D. 
The survey will be done by an online survey company called SurveyMonkey. If 
you choose to participant in this study, you will be sent login information to access the 
website. The survey will have 11 questions with five options for your response. The 
survey should take about 30 minutes to complete. Your personal information will not be 
used and your responses will be kept confidential. If you would like to participate in the 
study, please send an e-mail to rachel.connett@waldenu.edu. 
 








Appendix C: Cover Letter to Participants for Qualitative Data Collection 
Dear Participant,  
I am a Ph.D. graduate student with Walden University, Health Services program 
and I am covered by IRB Approval # 10-07-14-0078441 to conduct this study. This 
purpose of this study is to determine if MRI techniques can be used along with 
conventional mammograms to screen women with dense breast tissue for breast cancer 
detection. The primary reason of the study is to fulfill the university’s requirement for the 
student to gain her Ph.D. 
The survey will be done by the researcher through telephone interviews to collect 
responses to 5 questions. Each question will be given a response time of 3 to 5 minutes. 
The entire survey will take about 30 minutes to complete.  
Your personal information will not be used and your responses will be kept 
confidential. If you would like to participate in the study, please send an e-mail to 
rrachel.connett@waldenu.edu. 
 









Appendix E: Telephone Script for Researcher 
Hello Ms. Doe, thanks for taking the time to speak with me. My name is Rachel 
Connett, and I am a Ph. D. student and researcher with Walden University. I would like 
to understand the process from the time you began breast cancer screening until now as it 
is relevant to the different screening imaging techniques that were used to image dense 
breast tissue. Your feedback will help me to understand which technique, ultrasound   or 
MRI, is more effective to use with conventional mammogram for breast cancer detection 
in dense breast tissue. The information gathered will help women with dense breasts and 
the dense breast cancer community make an informed decision about the most effective 
imaging option they can make when they are presented with a dense breast diagnosis. 
Your participation in this interview and your responses will remain confidential. 







Appendix F: Research Study Questions for the Expert Panel 
How many years of experience have you had in interpreting screening mammographic 
images? 
How many years of experience have you had in interpreting MRI images for breast 
cancer? 
Was there a high percentage for repeat mammograms due to glandular breast tissue with 
conventional mammogram? 
Elaborate on conventional mammogram and ultrasound as screening methods for dense 
breast tissue. 
Does MRI have a higher specificity for dense breast tissue? 





Questionnaire for Quantitative Participants 
1. Is your age between 24 and 74 years? 
2. Are you in good health? 
3. Do you have a family history of breast cancer? 
4. Have you lost a family member to breast cancer who had regular mammography 
screenings? 
5. Do you regularly perform a breast self-exam? 
6. Do you have a screening mammogram every year? 
7. Have you had screening mammograms every year for the last five years? 
8. Have you had an abnormal mammogram finding? 
9. Did your doctor tell you that the result of your mammogram was not conclusive? 
10. Do you think a screening mammogram is the only available way to screen women 




















Is your age between 24 and 74 years?      
Are you in good health?      
Do you have a family history of breast 
cancer? 
     
Have you lost a family member to breast 
cancer? 
     
Do you regularly perform a breast self- 
exam? 
     
Do you have a screening mammogram 
every year? 
     
Have you had screening mammograms 
every year for the last five years 
     
Have you had an abnormal mammogram 
finding 
     
Did your doctor tell you that the result of 
your mammogram 
     
Do you think a screening mammogram is 
the only available way to screen women for 
breast cancer and did you have an 
ultrasound  







Questionnaire for Qualitative Participants: 
1. Are you in the age group of 24 to 74 years?  
2. Do you perform routine breast self-exams?  
3. Do you have a family history of breast cancer?  
4. Do you have an annual mammogram?  
5. Do you have dense breast tissue based on a mammogram?  
6. Were you told by her doctor that you needed a repeat mammogram? 
7. Have you had an ultrasound as a breast cancer screening?  
8. What was the finding? 
9. Did an MRI confirm your breast cancer diagnosis after the abnormal 
mammogram finding? 
10. Explain how you felt emotionally during the time it took for your doctor to 
make a diagnosis for your breast cancer. 
Do you believe that your breast cancer could have been detected earlier if MRI 





Appendix G: Expert Panelists 
Dr. Jafi Jipson, MD (Radiologist) 
Dr. Thomas Huang, MD (Clinician) 





Appendix H: Descriptives 
 N Minimum Maximum Mean Std. Deviation 
 Age 300 1 5 1.17 .473 
 Good health 300 1 5 1.63 .594 
 Family history of breast cancer 300 1 5 4.40 .567 
 Lost a family member to breast cancer 300 1 5 4.40 1.085 
 Regularly self-breast exam 300 1 5 1.92 .456 
 Screening mammogram every year 300 1 5 1.69 .572 
Screening mammograms every year for the 
last five 
300 1 5 2.84 1.570 
Abnormal mammogram  finding 300 1 5 2.01 .674 
 Result of your mammogram abnormal 300 1 5 4.12 1.296 
 Ultrasound after the screening mammogram 300 1 5 1.97 .767 






Appendix I: t Test One-Sample Statistics  
 
 N Mean Std. deviation Std. error 
mean 
Age 300 1.17 .473 .027 
Good health 300 1.63 .594 .034 
Family history of breast cancer 300 4.40 .567 .033 
Lost a family member to breast cancer 300 4.40 1.085 .063 
Regularly self-breast exam 300 1.92 .456 .026 
Screening mammogram every year 300 1.69 .572 .033 
Screening mammo every year for the last 5 
years 
300 2.84 1.570 .091 
Abnormal mammogram finding 300 2.01 .674 .039 
Result of your mammogram abnormal 300 4.12 1.296 .075 












Test value = 1 






of the difference 
Lower Upper 
 Age 6.343 299 .000 .173 .12 .23 
 Good health 18.453 299 .000 .633 .57 .70 
 Family history of breast cancer 103.930 299 .000 3.400 3.34 3.46 
 Lost a family member to breast 
cancer 
54.238 299 .000 3.397 3.27 3.52 
 Regularly self-breast exam 34.971 299 .000 .920 .87 .97 
 Screening mammogram every 
year 
20.999 299 .000 .693 .63 .76 
Screening mammograms every 
year for the last five 
20.263 299 .000 1.837 1.66 2.02 
Abnormal mammogram finding 25.854 299 .000 1.007 .93 1.08 
Result of your mammogram 
abnormal 
41.732 299 .000 3.123 2.98 3.27 
Ultrasound after the screening 
mammogram 





Appendix K: Major Themes 
 Participants  Age  Health Status  Annual Screen  Repeat Mammo US exam  Abnormal  




































Appendix O: Responses from Qualitative Interviews 
Participant 1: 
1. Are you in the age group 24 to 74 years? Yes, I am 68 years old. 
2. Do you perform routine breast self-exams? Yes, I do. That is how I found the lump 
in my left breast. 
3. Do you have a family history of breast cancer? No, my family does not have breast 
cancer.  
4. Do you have an annual mammogram? I have always had an annual mammogram, 
since I was in my 40s.  
5. Do you have dense breast tissue based on a mammogram? Yes. I think I was in my 
50s when my doctor told me I had “granular breast tissue.” He said there were areas 
in my left breast that he could see through. 
6. Were you told by your doctor that you needed a repeat mammogram? Yes, I had a 
repeat mammogram, which did not give more information than the previous one. 
7. Have you had an ultrasound as a breast cancer screening? An ultrasound exam was 
recommended. What was the finding? Not much different that the two mammograms 
that I had. My doctor recommended that if I am okay with it, that an MRI can be 
done to get more information, and a biopsy of the area can be done to get more 
information. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram 
finding? The uultrasound exam did not give new information, but the MRI did. The 
MRI was very uncomfortable: I was given an injection and had to lie on my chest for 
about 45 minutes. Then the doctor took a sample of my breast tissue and sent it to 
the lab. Thankfully, the area in question was very small and was taken out. I had 
radiation to kill any cancer cells that were there after the surgery. 
9. Explain how you felt emotionally during the time it took for your doctor to make a 
diagnosis for your breast cancer? It was very scary and nerve racking to wait for the 
results. I was upset because for so long I took good care of my health: annual 
physicals, blood tests, mammograms, and now, breast cancer. The good news is that 
the cancer did not spread, and my lymph nodes are ok. Now, all I have is an MRI 
every year, just to check for change. 
10. Do you believe that your breast cancer could have been detected earlier if MRI was 
utilized after your initial cancer diagnosed using mammograms? I think so. It seems 
like I was not diagnosed properly or misdiagnosed, and I wasted my time with the 
ultrasound especially, which was a waste of time. The MRI is not easy, but my 
doctor told me it is the best exam for my checkups.  
 
Participant #2 





2. Do you perform routine breast self-exams? Yes, since my children were born. 
3. Do you have a family history of breast cancer? No, neither side of my family. We 
have other things though: diabetes. 
4. Do you have an annual mammogram? Every year since I was 40.  
5. Do you have dense breast tissue based on a mammogram? Yes, my mammograms 
were clear until last year.  
6. Were you told by her doctor that you needed a repeat mammogram? Yes, my doctor 
ordered a diagnostic mammogram. At first, they diagnosed the areas as calcium, but 
continued to order more tests. Have you had an ultrasound    as a breast cancer 
screening? I had an ultrasound    exam which did not do much good, and the doctor 
said it looked suspicious. My doctor said it would be best to do more tests. He wrote 
a script for an MRI.  
7. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram 
finding? It was the most awful exam I ever had. It took so long. They made me lie on 
my chest, for a very long time. Then, the doctor took a tissue sample. My doctor’s 
office called me to come in to talk about the results. The results came back positive 
for cancer.  
8. Explain how you felt emotionally during the time it took for your doctor to make a 
diagnosis for your breast cancer? I was very scared. The time to wait for the results 
was almost two weeks.  
9. Do you believe that your breast cancer could have been detected earlier if MRI was 
utilized after your initial cancer diagnosed  using mammograms?  
10. I do not get it. How did the mammogram miss the cancer? I have so many questions 
about this. Needless to say, my annual breast screen is done with MRI only. 
 
Participant #3 
1. Are you in the age group of 24 to 74 years? I am 55 years old. 
2. Do you perform routine breast self-exams? Yes I do, every month. 
3. Do you have a family history of breast cancer? No family history, both sides. 
4. Do you have an annual mammogram? Yes, since age 40.  
5. Do you have dense breast tissue based on a mammogram? Yes. When I turned 50, 
my mammogram result was not conclusive and I had to do a repeat mammogram 
because my breast tissue was dense.  
Were you told by your doctor that you needed a repeat mammogram?  
6. I had a repeat mammogram. The technician said they needed more close up shots of 
the dense areas. 
7. Have you had an ultrasound as a breast cancer screening? I had an Ultrasound exam 
after the second mammogram. My doctor said the area was too small to diagnose, so 
I had an MRI exam. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram 





it out. Thank God, the area that they were not sure about was small, and the tumor 
was taken out.  
9. Explain how you felt emotionally during the time it took for your doctor to make a 
diagnosis for your breast cancer? I was totally scared. I have 2 children, both in 
college, and was scared of what I did not know. 
10. Do you believe that your breast cancer could have been detected earlier if MRI was 
utilized after your initial cancer diagnosed using mammograms? Absolutely. Not 
sure why the MRI was not done after the first mammogram. Since my diagnosis, I 
always get an MRI for my checkup. 
 
Response from Participant #4:  
 
1. Are you in the age group of 24 to 74 years? I am 45 
2. Do you perform routine breast self-exams? Yes. I am a nurse. 
3. Do you have a family history of breast cancer? No. 
4. Do you have an annual mammogram? Yes, since I was 35 years old 
5. Do you have dense breast tissue based on a mammogram? Yes, and my doctor told 
me it was ok, not to worry. 
Were you told by her doctor that you needed a repeat mammogram? Two years ago, 
my mammogram result was BI-RADS 4. 
6. Have you had an ultrasound as a breast cancer screening? Yes, and my doctor said 
he was not satisfied because the test did not give more information that the first 
mammogram 
7. What was the finding? Inconclusive. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram 
finding? Yes. The mammogram and ultrasound were both inconclusive. 
9. Explain how you felt emotionally during the time it took for your doctor to make a 
diagnosis for your breast cancer? I thought I was taking good care of myself when I 
started breast cancer screening at age 35. It was very frustrating to know that the 
mammogram did not detect the cancer earlier.  
10. Do you believe that your breast cancer could have been detected earlier if MRI was 
utilized after your initial cancer diagnosed using mammograms? Yes. I believe that 
the mammogram was ok, but the Ultrasound was useless, and that an MRI should 
have been ordered after the mammogram. 
 
Response from Participant #5: 
 
1. Are you in the age group of 24 to 74 years? 55 years. 
2. Do you perform routine breast self-exams? Yes 
3. Do you have a family history of breast cancer? No. 
4. Do you have an annual mammogram? Yes, since I was 40. 





Were you told by her doctor that you needed a repeat mammogram? Yes. My doctor 
said my mammogram was not clear because of the dense tissue.  
6. Have you had an ultrasound as a breast cancer screening? Yes, after the second 
mammogram. 
7. What was the finding? Not much else that the mammogram which was BI-RAD4. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram 
finding? The MRI was a horrible test. I had to lay to lay on my chest for over one 
hour. The biopsy came back positive for breast cancer. 
9. Explain how you felt emotionally during the time it took for your doctor to make a 
diagnosis for your breast cancer? The wait was the worst part. My family and I 
suffered because it took over one week to get the results. We kind of kneww after 
the tests that something was not right. 
10. Do you believe that your breast cancer could have been detected earlier if MRI was 
utilized after your initial cancer diagnosed using mammograms? Yes. If the MRI 
was done right after the first mammogram. I would have known the results and 
would have had the conversation with my doctor. 
 
Response from Participant #6: 
 
1. Are you in the age group of 24 to 74 years? I am 49. 
2. Do you perform routine breast self-exams? Yes, all the time. 
3. Do you have a family history of breast cancer? No cancer in the family, both sides 
are clear. 
4. Do you have an annual mammogram? Yes, since I was 40. 
5. Do you have dense breast tissue based on a mammogram? Yes. When I was 45, my 
mammogram came back with a BI-RADS4. The doctor explained that this number 
was too high and that I needed more tests. 
Were you told by her doctor that you needed a repeat mammogram? Yes, I had a 
diagnostic mammogram. 
6. Have you had an ultrasound as a breast cancer screening? An Ultrasound exam was 
recommended.  
7. What was the finding? The report said inconclusive, but suggest that there could be 
cancer. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram 
finding? Yes. Although the MRI was a hard test, they took a breast tissue after the 
MRI and sent it to the lab. 
9. Explain how you felt emotionally during the time it took for your doctor to make a 
diagnosis for your breast cancer? It took several weeks to get all the tests and the lab 
work done. The wait was terrible because I did not know. 
10. Do you believe that your breast cancer could have been detected earlier if MRI was 





was done after the first mammogram, I would have need so devastated. The 
ultrasound did not find much. 
 
Response from Participant #7: 
 
1.  Are you in the age group of 24 to 74 years? I am 48 years old. 
2. Do you perform routine breast self-exams? Yes 
3. Do you have a family history of breast cancer? No.  
4. Do you have an annual mammogram? Yes, since I was 40 years old 
5. Do you have dense breast tissue based on a mammogram? Yes, dense breast tissue 
was the finding three years ago. 
Were you told by her doctor that you needed a repeat mammogram? Yes. My 
mammograms were normal, but when I was 45, I had the bad news that I had to do 
more tests because there was an area in my left breast that was suspicious.  
6. Have you had an ultrasound as a breast cancer screening? Yes, an Ultrasound exam 
was recommended after the last mammogram. 
7. What was the finding? Inconclusive, because the area was too small for the 
ultrasound exam. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram 
finding? Yes, after both the mammogram and ultrasound exams and a biopsy, the 
result was cancer. 
9. Explain how you felt emotionally during the time it took for your doctor to make a 
diagnosis for your breast cancer? It took a toll on my health that something was 
wrong. I was a basket case. My family was affected so much because I have small 
children and I wanted to be around to take care of them. I was too young to die. 
10. Do you believe that your breast cancer could have been detected earlier if MRI was 
utilized after your initial cancer diagnosed using mammograms? Yes. I still do not 
understand how my mammograms were normal for five years and suddenly became 
abnormal. My doctor should have ordered an MRI sooner. 
 
Response from Participant #8: 
 
1. Are you in the age group of 25 and 75 years? I am 57 years old 
2. Do you perform routine breast self-exams? Yes, every month. 
3. Do you have a family history of breast cancer? No history, thank God. 
4. Do you have an annual mammogram? Yes, since I was 40. 
5. Do you have dense breast tissue based on a mammogram? Yes. When I turned 50, 
my mammogram result changes from normal to dense. 






6. Have you had an ultrasound as a breast cancer screening? After the repeat 
mammogram, my doctor was not convinced with the results and said an 
ultrasound exam was needed. 
7. What was the finding? My doctor said he was not convinced that the ultrasound 
gave better results. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal 
mammogram finding? I had an MRI and a biopsy that confirmed that the breast 
tissue was cancerous. 
9. Explain how you felt emotionally during the time it took for your doctor to make 
a diagnosis for your breast cancer? I waited almost one month to get approval and 
appointments to get all the tests done. It was mentally draining to know something 
was wrong, but did not know what. 
10. Do you believe that your breast cancer could have been detected earlier if MRI 
was utilized after your initial cancer diagnosed using mammograms? Yes, if the 
MRI was done after the first abnormal mammogram result, the stress would have 
been lessened for me and my family. The ultrasound did not find much. 
 
Response from Participant #9: 
 
1. Are you in the age group of 24 to 74 years? I am 57 years old. 
2. Do you perform routine breast self-exams? Yes, religiously. 
3. Do you have a family history of breast cancer? None. 
4. Do you have an annual mammogram? Every year since I was 40.  
5. Do you have dense breast tissue based on a mammogram? Not at first, but as I got 
older. I believe when I was 52, that was five years ago. I do not understand this. 
What in my body changed? 
Were you told by her doctor that you needed a repeat mammogram? Yes, I had a 
follow up repeat mammogram, where I had zoomed in pictures. I had BI-RADS4 
result. 
6. Have you had an ultrasound as a breast cancer screening? Yes. The BI-RADS 4 
prompted more testing. My doctor recommended an ultrasound exam. 
7. What was the finding? Not much more than the mammogram. And my doctor 
ordered an MRI test. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal 
mammogram finding? Yes. Although the MRI test was very hard for me to do, as 
I have problems with small spaces, I managed to finish the exam. The doctor took 
a tissue sample and sent it to the lab. The exam suggested breast cancer. 
9. Explain how you felt emotionally during the time it took for your doctor to make 
a diagnosis for your breast cancer? Very scared and devastateded. I felt like the 





10. Do you believe that your breast cancer could have been detected earlier if MRI 
was utilized after your initial cancer diagnosed using mammograms? Yes. I 
believe that the second exam should have needed an MRI. 
 
Response from Participant #10: 
 
1. Are you in the age group of 24 to 74 years? I am 30 years old. 
2. Do you perform routine breast self-exams? Yes, that is when found a lump. I had 
a sore area, and when I pressed on it, it was painful. 
3. Do you have a family history of breast cancer? Not at all 
4. Do you have an annual mammogram? Since I was 25 years old. 
5. Do you have dense breast tissue based on a mammogram? Yes. When I felt the 
lump, I made an appointment with my GP, and she wrote a script for a 
mammogram. 
Were you told by her doctor that you needed a repeat mammogram? I had to 
repeat the mammogram because I have dense tissue, and the mammogram was 
not able to see through the tissue and I was still having pain in my right breast. 
6. Have you had an ultrasound as a breast cancer screening? The radiologist 
recommended an ultrasound exam. 
7. What was the finding? Very technical jargon…but not conclusive. And I was still 
having pain. 
8. Did an MRI confirm your breast cancer diagnosis after the abnormal 
mammogram finding? The MRI showed that I had a small area that was 
suspicious for cancer and I had a biopsy which showed cancer cells. 
9. Explain how you felt emotionally during the time it took for your doctor to make 
a diagnosis for your breast cancer? It was nerve racking. I have no cancer history 
on both sides of my family, which puzzled my doctors.  
10. Do you believe that your breast cancer could have been detected earlier if MRI 
was utilized after your initial cancer diagnosed using mammograms? Yes, and a 
biopsy were done at the same time. The time it took to get in to do the tests was 
long. It seemed that my test was not urgent enough. If the MRI was done early, I 
would not be so stressed.  
  
 
